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ABSTRACT 
 
 
 
Non-melanoma skin cancer (NMSC), comprised of basal cell carcinoma (BCC) 
and squamous cell carcinoma (SCC), is the most common cancer in Caucasians.  
Ultraviolet radiation (UVR) exposure is the most important environmental risk factor for 
both BCC and SCC development.  However, the precise relationship between UVR and 
the risk of NMSC is complex, and the relationship may differ by skin cancer type.  It has 
been hypothesized that intermittent patterns and childhood sunlight exposure are 
important for BCC while continuous (chronic) and lifelong (i.e. childhood and adulthood) 
sunlight exposure is important for SCC.  Epidemiologic studies have demonstrated that 
cutaneous human papillomavirus (HPV) infection may also be a risk factor for 
developing NMSC.  However, the pathway by which cutaneous HPV is associated with 
NMSC remains unclear.  It is hypothesized that UVR exposure may interact 
synergistically with cutaneous HPV in NMSC development.   
The goal of the research study was to evaluate the relationship between levels of 
sunlight exposure and BCC and SCC and to investigate differences in sunlight-
associated BCC and SCC risk by genus-specific cutaneous HPV serostatus.  To 
address these goals, we conducted a clinic based case-control study of histologically 
confirmed BCC and SCC cases recruited from a university dermatology clinic and 
controls with no history of cancer and screened negative for current skin cancer.  
Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals 
(CI) for the associations between measures of sunlight exposure and BCC and SCC.  
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Multiplicative interactions were tested by placing an interaction term for the product of 
genus-specific HPV seroreactivity and sunlight related factors in the logistic regression 
models. 
 Measures of both intermittent and continuous patterns of sunlight exposure were 
associated with both types of skin cancer (i.e. BCC and SCC).  Specifically, history of 
blistering sunburn (a marker of intermittent sunlight exposure) and occupational sunlight 
exposure (i.e. having a job in the sun for ≥3 months for >10 years) were both associated 
with BCC and SCC.  The major differences in patterns of sunlight exposure between 
BCC and SCC were observed for sunlight exposure in one’s thirties.  Additionally, 
sunlight exposure in one’s twenties was associated with SCC, regardless of pattern of 
exposure; similar associations were not observed for BCC.  Measures of timing of 
sunlight exposure consistently demonstrated that childhood/adolescent sunlight 
exposure was more important for SCC than BCC.  These included number of moles on 
the forearms and entire body (measure of increased childhood sunlight exposure), and 
younger age at first and tanning bed use.  Younger age at first blistering sunburn was 
statistically significantly associated with both BCC and SCC.  
NMSC cases were more likely to be seropositive for cutaneous HPV antibodies 
compared to controls.  Compared to tanning, having a propensity to sun burn (p=0.006), 
or poor tanning ability (p=0.003) were significantly associated with a higher 
seroprevalence to genus beta HPV types within SCC cases.  Statistically significant 
interactions were observed between poor tanning ability and genus-specific 
seropositivity with NMSC.  Specifically, the associations between poor tanning ability 
and BCC (pinteraction=0.02) and SCC (pinteraction=0.01) were significantly stronger among 
individuals that were seropositive for antibodies to genus alpha HPV types.  Similarly, 
the association between poor tanning ability and SCC was stronger among those 
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seropositive for genus beta HPV types (pinteraction=0.001).  No additional significant 
interactions were observed for BCC or SCC between cutaneous sensitivity, history of 
blistering sunburn, or cumulative sunlight exposure and genus-specific seroreactivity.      
In conclusion, associations with patterns of sunlight exposure appeared to be 
similar between BCC and SCC cases.  With the exception of age at first blistering 
sunburn, factors measuring timing of sunlight exposure demonstrated stronger and 
statistically significant relationships with SCC. Additionally, of the sunlight related factors 
measured, only the associations between poor tanning ability and BCC and SCC were 
significantly modified by HPV seropositivity to types in genera alpha or beta. 
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CHAPTER 1: 
INTRODUCTION AND THEORETICAL FRAMEWORK 
 
Descriptive epidemiology of non-melanoma skin cancer 
Non-melanoma skin cancer (NMSC), comprised of basal cell carcinoma (BCC) 
and squamous cell carcinoma (SCC), is the most common cancer in Caucasians, with 
more than one million new cases diagnosed annually in the United States alone(1).  
While the mortality associated with NMSC is low(2), patients with multiple NMSC’s may 
experience substantial morbidity, and treatment costs for NMSC are high at the national 
level.  Furthermore, a history of NMSC has been consistently associated with increased 
risk of subsequent primary cancers of other sites in studies from both the U.S. and 
Europe(3-11).   
Risk factors for non-melanoma skin cancer 
Identified risk factors for BCC and SCC include older age, male sex, light eye 
(blue, green, or hazel), hair (red or blonde), and skin (fair) color, and 
immunosuppression(12).  Lifestyle factors such as smoking have also been proposed as 
risk factors for NMSC, mainly SCC, although findings are inconsistent across studies(13-
28).  Ultraviolet radiation (UVR) exposure has been implicated in the etiology of skin 
cancer and is considered the most important environmental risk for both BCC and SCC 
development.  However, the precise relationship between UVR and the risk of NMSC is 
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complex, and the relationship may differ by skin cancer type.  In addition to sunlight 
exposure, epidemiologic studies have demonstrated that cutaneous human 
papillomavirus (HPV) infection may be a risk factor for developing NMSC(29-38).  
However, the pathway by which cutaneous HPV is associated with NMSC remains 
unclear.  It is hypothesized that UVR exposure may interact synergistically with 
cutaneous HPV in NMSC development(34, 39-46).   
Patterns and Timing of sun exposure in basal cell and squamous cell carcinoma 
Beginning in the late 1950s, researchers began to conduct case-control studies 
to identify risk factors for NMSC, including total (cumulative) outdoor sunlight exposure 
hours and sunlight exposure on working and non-working days(19, 47-49).  
Observations from these studies helped recognize that BCC and SCC may have 
different exposure-response relationships with sunlight exposure.  However, few 
epidemiologic studies have formally evaluated the relationship between patterns and 
timing of sunlight exposure in BCC and SCC.  Patterns of exposure refer to whether 
sunlight exposure was experienced continuously (chronic exposure) or sporadically 
(intermittent exposure).  For example, persons working outdoors, such as farmers, or 
living in geographic regions with a high annual UV index, such as Florida, are classified 
as having had chronic sunlight exposure.  Alternatively, intermittent sunlight exposure 
refers to persons working indoors and experiencing most of their sunlight exposure on 
the weekends or persons living in northern latitudes with a low UV index being exposed 
to high doses of sunlight exposure while on vacation to regions with high UV index.  
Continuous or chronic sunlight exposure has been postulated to be associated with the 
development of SCC, whereas intermittent sunlight exposure has been observed to be 
associated with BCC.  Timing of sunlight exposure refers to what period in life the 
majority of a person’s exposure was received, in early childhood, adulthood or both.  
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Others have speculated that a high level of sunlight exposure in childhood is more 
strongly associated with BCC while exposure in adulthood is more strongly associated 
with SCC.   
Cutaneous human papillomavirus and UV radiation in non-melanoma skin cancer 
Human papillomaviruses belong to a large family of more than 100 genotypes, 
with genus alpha comprising types that infect predominantly mucosal epithelia (including 
“high-risk” types associated with cervical cancer and “low-risk” types inducing benign 
mucosal lesions), and types that infect cutaneous epithelia(50).  HPV types that infect 
cutaneous epithelia have also been identified from genera beta, gamma, mu, and 
nu(50).  Epidemiologic studies have demonstrated a potential role for cutaneous HPV 
infections in NMSC development.  Furthermore, it has been hypothesized that 
cutaneous HPV may interact synergistically with UV radiation exposure in NMSC 
development.  Several lines of evidence suggest that UV radiation exposure is 
associated with cutaneous HPV infection, and that these two factors may play a 
synergistic role in the development of cutaneous SCC.  UV radiation produces distinct 
mutations in DNA, and tandem mutations, specifically CC→TT transitions in the TP53 
gene (thymine dimers), are a hallmark of UV-induced DNA damage in SCC(42).  UV-B 
radiation can also stimulate the promoter activity of HPV 5 and 8(39). In turn, the E6 
proteins of genus beta HPV types have been shown to inhibit UV radiation-induced 
apoptosis through p53-independent pathways(45, 46), and cells expressing the E6 
protein of HPV type 5 have reduced capacity to repair UV radiation-induced thymine 
dimers(43).  In addition, HPV 38 E6 and E7 can alter the regulation of cell cycle 
checkpoints activated by UV radiation(41).   
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Limitations in literature 
 There are several limitations in the literature that should be addressed.  Studies 
investigating the associations between the amount, patterns, and timing of sunlight 
exposure and NMSC are few in number and have been limited to populations outside of 
the United States(51-53), with the exception of the study conducted by Vitasa et al 
among watermen from Maryland.  However, Vitasa et al measured cumulative exposure 
to UVB while the other studies(51-53) conducted among residents from Southern 
Europe and Australia used indirect measurements of sunlight exposure such as hours 
spent outdoors. Measuring lifetime sunlight exposure is difficult and measurement 
methods have varied across studies making it difficult to compare results.    
Evidence in the published literature investigating the association between 
cutaneous HPV infection and NMSC is limited, and more epidemiologic studies are 
needed to better understand the association between UV radiation exposure and 
cutaneous HPV infection as they relate to NMSC development.  A majority of the studies 
investigating the association between cutaneous HPV seropositivity and NMSC only 
included cutaneous HPV types from genus beta and did not present stratified analyses 
by factors, such as sunlight exposure, that may explain the variability observed across 
study populations.  
Public health significance 
Non-melanoma skin cancer (NMSC), comprised of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC), is the most frequently occurring cancer among 
U.S. men and women.  Exposure to Ultraviolet (UV) radiation is an established risk 
factor for NMSC, but despite the current knowledge about the harm of sunlight exposure, 
and increased use of sunscreen, NMSC incidence rates continue to increase, 
5 
 
emphasizing the critical need to better understand the role of sunscreen use in 
preventing NMSC and differences in sunlight exposure response relationships for BCC 
and SCC.  Furthermore, it’s important to identify additional risk factors for NMSC that 
may better characterize individuals at high risk and aid in the development of novel 
prevention strategies. 
Many epidemiologic studies provide evidence for the role of UV radiation 
exposure in the etiology of all types of skin cancer.  However, few studies have formally 
evaluated the association between patterns and timing of sunlight exposure as they 
relate to BCC and SCC.  Understanding how sunlight exposure response differs for BCC 
and SCC is important for better educating the public in sun safe behaviors.  Simply 
advising a reduction in sunlight exposure will not help reduce the incidence of NMSC if 
changes in sunlight exposure patterns are related to skin cancer development.  For 
example, reducing continuous sunlight exposure (i.e. high doses of daily sunlight 
exposure) may decrease the incidence of SCC but not BCC if intermittent sun exposure, 
as experienced on holidays and vacations, is still received in high doses.  Epidemiologic 
studies conducted in several countries have demonstrated an association between 
cutaneous HPV infection and NMSC, particularly SCC, and there is limited evidence to 
support the interaction between sunlight exposure and cutaneous HPV seropositivity as 
they relate to SCC.  There is growing interest in utilizing a vaccine approach to 
preventing cancers caused by HPV, such as NMSC.  However, much remains to be 
understood regarding the epidemiology of cutaneous HPV infections and their 
relationship with UV radiation exposure and NMSC development before such an 
approach can be incorporated into public health practice.   
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Specific Aims 
Non-melanoma skin cancer (NMSC), comprised of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC), is the most frequently occurring cancer among 
U.S. men and women, with an estimated annual case burden of more than one million 
cases.  NMSC, though not as fatal as other cancers, is associated with high treatment 
costs at the national level and an increased risk of developing other cancers.  Exposure 
to ultraviolet (UV) radiation has been established as a risk factor for NMSC.  Evidence 
from previous studies suggest that intermittent sunlight exposure is important for the 
pathogenesis of BCC, whereas cumulative sunlight exposure is important for both BCC 
and SCC, but the exact relationship between patterns and timing of sunlight exposure 
and risk of BCC and SCC still remain unclear. 
With UV radiation exposure being the most important environmental risk factor 
for NMSC and increasing annual incidence of NMSC despite the increased use of 
sunscreen products, there is a need to identify cofactors that may interact with UV 
radiation exposure to increase the risk of NMSC so novel prevention strategies can be 
developed.  Epidemiologic studies have demonstrated that cutaneous human 
papillomavirus (HPV) infection may be a risk factor for developing NMSC.  DNA from 
cutaneous HPV types, especially genus beta types, have been detected in NMSC 
tissues, and antibodies against genus beta HPV types have been associated with a 50-
400% increased risk of NMSC in several epidemiologic studies.  However, the pathway 
by which cutaneous HPV is associated with NMSC remains unclear.  It is hypothesized 
that UV radiation exposure may interact synergistically with cutaneous HPV in NMSC 
development. 
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Identifying how differences in sunlight exposure and cutaneous HPV infections 
influence the development of BCC and SCC may help characterize individuals at high 
risk and aid in the development of novel prevention strategies.  Utilizing data collected 
from a previous case control study of NMSC funded by a James and Esther King 
Biomedical Research Grant (30-14953-99-01), we conducted a case-control analysis of 
sunlight exposure and cutaneous HPV seropositivity in NMSC among control patients 
recruited from Moffitt’s Lifetime Cancer Screening and Prevention Clinic and the 
University of South Florida (USF) Family Medicine Clinic and among NMSC patients 
recruited from the USF Dermatology Clinic.  The goal of the research study was to 
evaluate the relationship between levels of sunlight exposure and BCC and SCC and to 
investigate differences in sunlight-associated BCC and SCC risk by genus-specific 
cutaneous HPV serostatus.  The specific aims for the current study were: 
1) To evaluate the association between self-reported patterns (continuous vs. 
intermittent) of sunlight exposure and BCC and SCC of the skin. 
2) To evaluate differences in the associations between self-reported timing 
(childhood vs. adulthood) of sunlight exposures and BCC and SCC of the skin. 
3) To investigate the interaction effects of genus-specific cutaneous HPV 
seroreactivity and measures of sunlight exposure as they relate to BCC and 
SCC of the skin. 
We hypothesized that intermittent and childhood sunlight exposure will be 
associated with BCC and that chronic, life-long sunlight exposure will be associated with 
SCC.  Finally, we hypothesize that sunlight exposure will be associated with BCC and 
SCC more strongly among those who are seropositive for antibodies to one or more 
cutaneous HPV types. 
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The current study is innovative in that it will be the first study to formally evaluate the 
relationship between measures of patterns and timing of sunlight exposure in a high risk 
U.S population.  It will also be the first to estimate interaction and joint effects between 
measures of sunlight exposure (i.e. patterns and timing) and cutaneous HPV 
seropositivity among a U.S. population.  Findings from the proposed study will be of 
potential public health significance by identifying how differences in patterns and timing 
of sunlight exposure relate to BCC and SCC.  Furthermore, results from the current 
study may potentially provide evidence to support the interaction between sunlight 
exposure and cutaneous HPV as they are related to BCC and SCC.  This information 
may help identify high-risk individuals and aid in the development of novel prevention 
strategies with the intent of reducing the burden of NMSC in populations experiencing 
high UVR exposure. 
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CHAPTER 2: 
CASE-CONTROL STUDY OF PATTERNS AND TIMING OF SUNLIGHT 
EXPOSURE IN BASAL CELL AND SQUAMOUS CELL CARCINOMAS OF THE SKIN 
 
Abstract 
A case-control study was conducted among Florida residents in the United States to 
investigate identical measures of patterns (intermittent vs. continuous) and timing 
(childhood vs. adulthood) of sunlight exposure in basal (BCC) and squamous (SCC) cell 
carcinomas of the skin.  Participants included 218 BCC and 169 SCC cases recruited 
from a university dermatology clinic and 316 controls with no history of skin or other 
cancers.  A history of blistering sunburn (a measure of intermittent sunlight exposure) 
was associated with both BCC and SCC.  Additionally, having a job in the sun for ≥3 
months for 10 years or longer (a measure of continuous sunlight exposure) was also 
associated with both BCC and SCC in our study population.  Measures of timing of 
sunlight exposure included the presence of moles on one’s forearms and entire body (a 
marker of increased childhood sunlight exposure), age at first blistering sunburn and age 
at first tanning bed use.  With the exception of younger age at first blistering sunburn, 
measures of younger age at sunlight exposure tended to be associated with SCC, but 
not BCC risk.  Results from the current study provided evidence that both intermittent 
and continuous patterns of sunlight exposure may be important in both BCC and SCC 
risk.  Additionally, it appeared as though sunlight exposure at younger age was 
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important for SCC but not BCC in our study population.  Further studies are required to 
identify potential differences or similarities in exposure-response relationships in different 
types of non-melanoma skin cancer. 
Introduction 
Non-melanoma skin cancer (NMSC), comprised of basal cell (BCC) and 
squamous cell (SCC) carcinomas, is the most common cancer in Caucasians, with more 
than one million new cases diagnosed annually in the United States (U.S.) alone(1).  
While the mortality associated with NMSC is low(2, 54), patients with multiple NMSC’s 
may experience substantial morbidity, and treatment costs for NMSC are high at the 
national level(55).  Furthermore, a history of NMSC has been consistently associated 
with increased risk of subsequent primary cancers of other sites in studies from both the 
U.S. and Europe(3-11).   
Ultraviolet radiation (UVR) exposure is considered the most important 
environmental risk for both BCC and SCC.  However, the precise relationship between 
UVR and the risk of NMSC is complex, and the relationship may differ by skin cancer 
type.  Starting in the late 1950s, researchers began to identify total (cumulative) outdoor 
sunlight exposure hours and sunlight exposure on working and non-working days(19, 
47-49) as risk factors for NMSC.  Results from these studies suggested that BCC and 
SCC may have different exposure-response relationships with sunlight.     
Patterns of sunlight exposure are continuous (i.e. persons working outdoors or 
living in a geographic region with a high annual UV index) or intermittent (i.e. persons 
working indoors and experiencing most of their sunlight exposure on the weekends or 
while vacationing to regions with a higher UV index than their place of residence).  
Timing of sunlight exposure refers to the period of life during which the majority of a 
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person’s sunlight exposure was experienced: childhood/adolescence, adulthood or both.  
Evidence from previous studies suggests that intermittent and childhood sunlight 
exposure may be important for the pathogenesis of BCC, whereas continuous, lifelong 
sunlight exposure may be important for SCC(52, 53, 56-58).  
 A major limitation of previously published studies is that they do not present 
direct comparisons between BCC and SCC from the same study population for 
associations with measures of patterns and timing of sunlight exposure.  Therefore, 
differences in the observed associations may be explained by methodological 
inconsistencies in exposure measurement between study populations that investigate 
BCC or SCC alone.  This is the first case-control study to simultaneously evaluate 
identical measures of patterns and timing of sunlight exposure as they are related to 
both BCC and SCC in the same U.S. population with high annual UVR exposure.  The 
goal of the current study was to identify potential differences or similarities in sunlight 
exposure responses for BCC and SCC risk. 
Materials and methods 
Study design and population 
A clinic-based case-control study was conducted to evaluate the relationship 
between patterns and timing of sunlight exposure and risk of BCC and SCC.  Complete 
study procedures have been described in detail elsewhere(59).  The University of South 
Florida (USF) Dermatology (D) clinic served as the primary location for recruitment of 
NMSC cases, comprised of patients with histologically-confirmed BCC or SCC.  Control 
participants were recruited from the USF Family Medicine (FM) clinic and Moffitt’s 
Lifetime Cancer Screening (LCS).  Controls were individuals who self-reported no history 
of skin or other types of cancer and underwent a skin cancer screening exam at the time 
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of study enrollment and screened negative for skin cancer.  Additionally, any patient that 
screened positive for a suspicious lesion, underwent a biopsy and were determined to 
be negative for skin cancer were also included as controls.  All participants were 
recruited between October 30, 2006 and December 24, 2008.   All participants provided 
written informed consent, and all study procedures were approved by the institutional 
review board at the University of South Florida. 
Participation rates for the USF-D, the USF-FM, and LCS clinics were 80%, 47%, 
and 65%, respectively.  There were no statistically significant differences in age or 
gender between those NMSC patients who agreed to participate and those that refused.  
The current study population was restricted to White individuals and includes 218 BCC 
and 169 SCC cases and 316 controls, between the ages of 18 and 80.   
Exposure assessment 
Self-administered questionnaires were used to obtain information on sunlight 
exposures and potential confounding factors, including age, gender, ethnicity, education, 
eye and hair color, ever smoking, skin sensitivity to sunlight exposure (measured by skin 
reaction to one hour of sunlight exposure for the first time without sunscreen), and 
tanning ability (measured by change in skin color to repeated exposure to the summer 
sun).  Patterns of sunlight exposure were measured using questions on history of 
blistering sunburn (yes/no), ever having a job in the sunlight for ≥3 months (yes/no), the 
number of years with a job in the sunlight for ≥3 months (<1, 1-5, 6-10, or >10 years), 
lifetime frequency of tanning bed use (≤10, 11-50, 51-100, >100 times), frequency of 
sunscreen application with a sunlight protection factor (SPF) of ≥15 when outside for 
more than 15 minutes during the summer (always, often, sometimes, rarely, never), and 
the number of hours of mid-day sunlight exposure on a typical weekday (<1, 1-2, 3-4, 5-
6 hours) and weekend day (<1, 1-2, 3-4, 5-6 hours) in the summer during one’s teen 
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years, twenties, thirties, and the past ten years prior to study enrollment.  Experiencing 
blistering sunburn is considered a marker of intermittent sunlight exposure.  Additionally, 
using sunscreen always/often or rarely/never is considered experiencing continuous 
sunlight exposure and using sunscreen some of time is considered intermittent sunlight 
exposure. 
Timing of sunlight exposure was measured using questions on the age at which 
a blistering sunburn was experienced (≤5, 6-10, 11-15, 16-20, >20 years), the number of 
moles larger than one quarter of an inch in diameter on the forearms (none, <10, 10-25, 
>25 moles) and on the entire body (none, <10, 10-25, >25 moles), the age at first 
tanning bed use (≤15, 16-20, >20 years),  and the number of hours of mid-day sunlight 
exposure on a typical weekday (<1, 1-2, 3-4, 5-6 hours) and weekend day (<1, 1-2, 3-4, 
5-6 hours) in the summer during one’s teen years, twenties, thirties, and in the past ten 
years prior to study enrollment.  The presence of moles is considered an indicator of 
increased sunlight exposure in childhood or adolescence(60-65). 
Statistical analysis 
Demographic and skin cancer risk factors were compared between cases and 
controls using the chi-square test.  To test whether measures of patterns or timing of 
sunlight exposure were associated with BCC or SCC, separate odds ratios (OR) and 
corresponding 95% confidence intervals (CI) for each skin cancer type were calculated 
using unconditional logistic regression.  Backward stepwise elimination was used to 
identify confounders from those factors previously shown to be associated with sunlight 
exposure and NMSC, including age (as a continuous variable), gender, ethnicity, 
education, eye, hair, and un-tanned skin color, cutaneous sensitivity and tanning ability 
to sunlight exposure, history of ever smoking, and alcohol consumption in the past year.  
Each factor retained in the model at p<.10 was included in the final regression models; 
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these factors include age, gender, ethnicity, education, eye and hair color, cutaneous 
sensitivity, tanning ability, and history of ever smoking.  Variance inflation factors and 
Pearson correlation coefficients were estimated to identify multicollinear relationships 
between independent risk factors.  No collinearity between co-factors and measures of 
patterns and timing of sunlight exposure was observed. 
Factors associated with skin susceptibility factors to sunlight exposure have the 
potential to be factors on the causal pathway between UVR exposure and skin cancer.  
Therefore, to demonstrate the impact of these factors on the associations of interest, we 
present results from two different multivariate analyses.  The first multivariate analysis 
adjusted for demographic and lifestyle factors only (i.e. age, gender, education, and 
history of ever smoking) and the second adjusted for demographic and lifestyle factors, 
as well as measures of skin susceptibility to sunlight exposure (i.e. ethnicity, eye and 
hair color, cutaneous sensitivity and tanning ability to sunlight exposure).   
 To compare the effects sizes between BCC and SCC for each sun-related factor 
measured a case-only analysis was conducted.  OR and 95% CI were estimated using 
logistic regression where the dependent variable included NMSC cases only (1=BCC; 
0=SCC).  A p-value <0.05 for the beta coefficient for each sunlight related factor was 
considered statistically significant for differences in the magnitudes of associations 
observed for each independent factor. 
Utilizing data collected on the number of hours of sunlight exposure experienced 
on a typical weekday and weekend day during the summer in different time periods, 
summary scores were calculated.  To measure cumulative sunlight exposure in early life 
(i.e. teens, twenties, and thirties), a median value was applied to each category of hours 
of sunlight exposure (<1 hour=0.5; 1-2 hours=1.5; 3-4 hours=3.5; 5-6 hours=5.5) on a 
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weekday and weekend day.  The median values for weekday and weekend sunlight 
exposure were summed for each age group and then summed across the age groups 
(i.e. teens, twenties, and thirties) and divided into three categories: low, medium, and 
high.  For intermittent sunlight exposure in early life, median values were once again 
applied to each category of hours of sunlight exposure.  The ratio of median hours on a 
weekend day relative to that on a weekday was estimated separately for one’s teen 
years, twenties, and thirties, summed across the three decades, and divided into three 
groups: low (representing continuous sunlight exposure), medium, and high.  Analyses 
including summary scores measuring sunlight exposure in early life were restricted to 
participants who were ≥40 years of age.       
For patterns of sunlight exposure by age at exposure (i.e. one’s teens, twenties, 
thirties, and the 10 years prior to study enrollment), the participant was considered as 
having had continuous sunlight exposure if the reported number of hours of weekday 
sunlight exposure (1-2 or 3-6 hours) equaled that of weekend sunlight exposure (1-2 or 
3-6 hours).  However, if the reported number of hours of weekday sunlight exposure was 
less than that of weekend sunlight exposure, then the participant was considered as 
having intermittent sunlight exposure.  Participants classified as having continuous or 
intermittent sunlight exposure were compared to participants with <1 hour of sunlight 
exposure on a typical weekday and weekend day.  Daily sunlight exposure by age at 
exposure was measured by summing the median values of weekday and weekend 
hours of sunlight exposure and then dividing the values into three categories: low, 
medium, and high, independently for each time period. 
All analyses were performed using the SAS statistical software package (version 
9.1.3; SAS Institute). 
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Results 
Demographic, lifestyle, and skin susceptibility factors are presented for cases 
and controls in Table 1.  Compared to controls, cases were significantly more likely to be 
male (BCC: p=<.0001; SCC: p=<.0001), older in age (BCC: p=<.0001; SCC: p=<.0001), 
less educated (BCC: p=0.0004; SCC: p=0.001), and ever smokers (BCC: p=0.002; SCC: 
p=<.0001).  Additionally, NMSC cases were more likely to have light eye and hair color, 
a greater tendency to burn and a lesser tendency to tan from sunlight exposure, 
compared to controls.  
 Associations between patterns of sunlight exposure and NMSC are presented in 
Table 2.  When adjusting for demographic and lifestyle factors only, a history of blistering 
sunburn was positively associated with both BCC (OR=1.96, 95% CI=1.27-3.03) and 
SCC (OR=2.02, 95% CI=1.22-3.33).  Ever having a job in the sunlight for ≥3 months was 
significantly associated with SCC (OR=1.73, 95% CI=1.06-2.83) but not BCC (OR=1.38, 
95% CI=0.89-2.14).  However, having a job in the sunlight for ≥3 months for >10 years 
was significantly associated with both BCC (OR=2.14, 95% CI=1.12-4.11) and SCC 
(OR=2.54, 95% CI=1.23-5.28).  With the exception of having a job in the sunlight for >10 
years, the associations described above were no longer statistically significant when 
adding skin susceptibility co-factors to the multivariate models.  When adjusting for 
demographic and lifestyle factors only, no associations were observed between levels of 
cumulative sunlight exposure or patterns of exposure in one’s twenties or thirties and 
either BCC or SCC.  However, after additional adjustment for measures of skin 
susceptibility, medium levels of cumulative sunlight exposure were associated with BCC 
(OR=1.88, 95% CI=1.07-3.31) and medium (OR=2.36, 95% CI=1.22-4.57) and high 
(OR=1.25-4.91) levels of cumulative sunlight exposure were significantly associated with 
SCC, compared to low levels in early life.  Additionally, sunlight exposure in one’s 
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twenties was associated with SCC regardless of the pattern of exposure; specifically, an 
OR of 2.99 (95% CI=1.19-7.48) was associated with continuous hours and an OR of 
3.15 (95% CI=1.27-7.83) was associated with intermittent hours of exposure compared 
to <1 hour of sunlight exposure.  Finally, in one’s thirties, statistically significant 
associations were observed between intermittent hours of sunlight exposure and BCC 
(OR=2.09, 95% CI=1.11-3.93) while continuous hours of sunlight exposure were 
associated with SCC (OR=2.25, 95% CI=1.02-4.94), compared to <1 hour of exposure, 
when adjusting for skin susceptibility co-factors.  Regardless of the covariates included 
in the multivariate models, no statistically significant associations in BCC or SCC were 
observed with tanning bed use, sunscreen use, levels of intermittent sunlight exposure in 
early life, and patterns of sunlight exposure in one’s teens and the past ten years prior to 
study enrollment. 
 Table 3 presents the associations between measures of timing of sunlight 
exposure and BCC and SCC.  When adjusting for demographic and lifestyle factors only, 
associations with SCC were observed for the presence of >10 moles on the forearms 
(OR=3.27, 95% CI=1.12-9.58) and entire body (OR=2.12, 95% CI=1.11-4.06), compared 
to no moles.  Similar associations were not observed with BCC.  Experiencing a 
blistering sunburn in young childhood or adolescence was significantly associated with 
both BCC (<10 years: OR=1.97, 95% CI=1.14-3.42; 10-20 years: OR=2.15, 95% 
CI=1.32-3.52) and SCC (<10 years: OR=2.25, 95% CI=1.22-4.13; 10-20 years: 
OR=2.37, 95% CI=1.34-4.21), compared to never experiencing blistering sunburn.  SCC 
cases were more likely to begin using a tanning bed prior to age 20 (OR=1.97, 95% 
CI=1.01-3.85), compared to never users.  No significant associations with BCC were 
observed for age at first tanning bed use.  Elevated OR estimates were observed for 
high levels of daily sunlight exposure during the summer with BCC and SCC across all 
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time periods, however, none of these associations achieved statistical significance.  
When including measures of skin susceptibility to sunlight exposure to the multivariate 
models, little differences were observed in the magnitudes of associations between 
measures of timing of sunlight exposure and BCC/SCC. 
 In summary, measures of both intermittent and continuous patterns of sunlight 
exposure were associated with both types of skin cancer (i.e. BCC and SCC).  
Specifically, history of blistering sunburn (a marker of intermittent sunlight exposure) and 
occupational sunlight exposure (i.e. having a job in the sun for ≥3 months for >10 years) 
were both associated with BCC and SCC.  The major differences in patterns of sunlight 
exposure between BCC and SCC were observed for sunlight exposure in one’s thirties 
when adjusting for skin susceptibility factors.  Additionally, sunlight exposure in one’s 
twenties was associated with SCC, regardless of pattern of exposure; similar 
associations were not observed for BCC.  Measures of timing of sunlight exposure 
consistently demonstrated that childhood/adolescent sunlight exposure was statistically 
significantly more important for SCC.  However, despite differences in statistical 
significance in sun-related factors between BCC and SCC, case-only analyses 
demonstrated that the observed ORs were not significantly different in magnitude 
between BCC and SCC for measures of patterns and timing of sunlight exposure (data 
not shown). 
Discussion 
A clinic based case-control study was conducted to identify associations between 
patterns and timing of sunlight exposure and two types NMSC, BCC and SCC.  It has 
been suggested that BCC and SCC risk may differ by the patterns and timing in which 
sunlight exposure was received.  Unlike previously published studies, we investigated 
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multiple measures of sunlight exposure in BCC and SCC simultaneously and many 
similarities were observed in measures of intermittent and continuous patterns of 
sunlight exposure between the two types of skin cancer.  For example, history of 
blistering sunburn, having a job in sun for >10 years, and cumulative sunlight exposure 
in early life were associated with both BCC and SCC.  With the exception of 
experiencing blistering sunburn at a younger age, measures of timing of sunlight 
exposure tended to be more important for SCC than BCC risk.  For example, the 
presence of moles on one’s forearms or entire body (a marker of childhood/adolescent 
sun exposure) was associated with SCC, but not BCC.  Additionally, using a tanning bad 
for the first time at a younger age was positively associated with SCC, but not BCC. 
Previous studies that aimed to quantify the association between the amount of 
sunlight exposure and NMSC have provided evidence to support the hypothesis that 
intermittent sunlight exposure is associated with BCC(52, 66) while chronic sunlight 
exposure is associated with SCC(13, 24, 49, 51, 53, 67) .  Utilizing similar information as 
previous studies (i.e. number of hours of sunlight exposure to define intermittent and 
continuous exposure), findings from the current study provide evidence that BCC and 
SCC risk do not differ by patterns of exposure, but in fact that intermittent and 
continuous patterns of sunlight exposure are important for both BCC and SCC.  
Additionally, information from previous studies investigating measures of sunlight 
exposure, such as blistering sunburn, has been used to potentially support the current 
hypotheses regarding patterns of sunlight exposure and NMSC.  A history of blistering 
sunburn (an indicator of intermittent sunlight exposure) was positively associated with 
both BCC and SCC in our study population.  This agrees with two case-control studies of 
SCC(53, 67) , but contradicts observations from four studies of BCC(14, 52, 67, 68) and 
one of SCC(68).  Blistering sunburn is believed to result from high doses of intense UVR 
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exposure in short increments of time.  Therefore, it’s considered a measure of 
intermittency.  However, blistering sunburn is also a measure of cutaneous sensitivity to 
sunlight exposure and may explain the observed associations in our study population for 
both BCC and SCC when co-factors measuring skin susceptibility to sunlight exposure 
were excluded from the multivariate models. 
It has been estimated that approximately 25% of lifetime sunlight exposure 
occurs before 18 years of age(69).  Young childhood and adolescence is considered a 
time period when individuals have greater vulnerability to toxic exposure, such as 
UVR(69).  Associations with first occurrence of blistering sunburn during childhood or 
adolescence (age periods prior to skin cancer diagnosis) were similar for BCC and SCC 
risk in our study population.  However, among residents of Western Australia, blistering 
sunburn between 10 to 14 years of age was associated with BCC(52) while sunburn 
between 35 to 39 years of age was associated with SCC(53). Many epidemiologic 
studies have investigated the association between sunlight exposure in early childhood 
and nevus development and provide evidence that increasing sunlight exposure in early 
years of life is associated with melanocytic nevus development(60-65).  Since most nevi 
develop by the age of 10, their presence in adulthood may be considered an indicator of 
high UV exposure in childhood.  Self-reported presence of >10 moles on the entire body 
were significantly and positively associated with SCC in our study population.  Similar 
results were not observed for BCC.  A limited number of studies have reported findings 
for the association between the presence of moles and NMSC, of which, one case-
control study from Western Australia(70) and one prospective cohort study of U.S. male 
health professionals(27) observed a positive dose-response relationship between an 
increasing number of moles and BCC.  In contrast, among adults from the U.S.(68), the 
presence of moles was not associated with either BCC or SCC risk. 
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The current study has some limitations.  Clinic based study populations are not 
necessarily representative samples of the general population.  Case-control studies are 
often subject to recall bias because cases tend to think about their exposures more 
carefully as they might relate to their current cancer diagnosis.  The sample size was 
small, limiting the ability to detect statistically significant associations, especially when 
adjusting for multiple co-factors.  Few differences were observed in the magnitudes of 
the estimated effects when adjusting for skin susceptibility factors.  However, when 
including these factors in the multivariate model, precision decreased and in some 
instances statistical significance was no longer observed, mostly likely due to a decrease 
in the sample size.   
Unlike previous studies(51-53), we measured intermittency of sunlight exposure 
in the current study by assuming that weekend hours were “non-working” hours for our 
study population and we were unable to estimate “lifetime” sunlight exposure or consider 
the amount of ambient solar irradiance received by study participants.  Additionally, 
sunlight exposure was not assessed at the site of BCC or SCC diagnosis, as done in 
previous studies(52, 53).  Depending on the site of skin cancer diagnosis, this may result 
in participants underestimating the amount of sunlight exposure to the site of skin cancer 
diagnosis which, in turn would result in small effect differences being observed.  
Approximately 61% of skin cancers in our study population occurred on the face.  Since 
the face is chronically exposed to sunlight exposure regardless of the outdoor activity or 
type of clothing being worn (even hats do not block or filter 100% of UV radiation), this 
could result in participants under-reporting their sunlight exposure.  We also did not 
collect information on sunlight exposure during holidays or recreational activities.  It is 
difficult to compare results across studies for the relationship between sunlight exposure 
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and skin cancer due mainly to inconsistencies and variations in the methods used to 
measure sunlight exposure.   
The current study is the first case-control study to formally evaluate measures of 
patterns and timing of sunlight exposure in NMSC in a high risk U.S. population as well 
as present findings simultaneously for both skin cancer types, BCC and SCC.  This 
presentation allowed for direct comparisons of patterns and timing of sunlight by skin 
cancer type.  The controls were screened for current signs of BCC and SCC by a nurse 
practitioner to avoid misclassification of case-control status that may result from self-
reported data.  This is an important strength of our study as a portion of the screened 
patients were included as cases in the current study population.    
The current study does not support clear differences in the exposure response 
relationships between patterns of sunlight exposure for BCC and SCC.  We conducted a 
case-only analysis to identify statistically significant differences in the observed ORs 
between BCC and SCC.  Results of this analysis provided evidence to support that the 
associations between patterns of sunlight exposure were in fact more similar, than 
different for each type of NMSC.  Based on the evidence provided by the current study 
we conclude that both intermittent and continuous patterns of sunlight exposure are 
important for both BCC and SCC risk.  Additionally, despite statistically significant ORs 
observed between measures of timing of sunlight exposure and SCC, the case-only 
analysis revealed no strong differences in timing of sunlight exposure between BCC and 
SCC.   
Understanding how sunlight exposure responses may potentially differ by NMSC 
type is important for better educating the public in sun safe behaviors.  Simply advising a 
reduction in sunlight exposure will not help reduce the incidence of NMSC if changes in 
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sunlight exposure patterns are related to skin cancer development.  For example, 
applying sunscreen while on vacation may decrease BCC risk associated with 
intermittent sunlight exposure, but may not impact the risk of SCC, which may be more 
strongly related with continuous sunlight exposure.  Further studies are needed to 
highlight similarities and differences in the exposure-response relationship of patterns 
and timing of sunlight exposure with BCC and SCC.  Furthermore, standardized 
methods for measuring sunlight exposure should be established to enable comparisons 
across different study populations.   
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Table 2.1. Demographic, life-style, and skin cancer risk factors in basal cell and 
squamous cell carcinoma cases and controls 
 Controls  BCC SCC 
 (n = 316)  (n = 218) (n = 169) 
Variable n (%)  n (%) p1 n (%) p1
Age mean(S.D.) 55.6 (11.8)  62.8 (11.9) <.0001 64.8 (9.6) <.0001
Age (years) 
  18-29 
  30-39 
  40-49 
  50-59 
  60-69 
  70-80 
 
9 (2.9) 
21 (6.7) 
55 (17.4) 
109 (34.5) 
88 (27.9) 
34 (10.8)
  
1 (0.5) 
6 (2.8) 
24 (11.0) 
46 (21.1) 
64 (29.4) 
77 (35.3)
 
 
 
 
 
 
<.0001
 
1 (0.6) 
2 (1.2) 
10 (5.9) 
30 (17.8) 
68 (40.2) 
58 (34.3) 
 
 
 
 
 
 
<.0001
Gender 
  Male 
  Female 
 
117 (37.0) 
199 (63.0)
  
133 (61.0) 
85 (39.0)
 
 
<.0001
 
108 (63.9) 
61 (36.1) 
 
 
<.0001
Ethnicity 
  Non-Hispanic 
  Hispanic 
 
280 (88.6) 
32 (10.1)
  
208 (95.4) 
7 (3.2)
 
 
0.003
 
161 (95.3) 
2 (1.2) 
 
 
0.0003
Education 
  ≤ 12 years 
  > 12 years 
 
32 (10.1) 
280 (88.6)
  
46 (21.1) 
168 (77.1)
 
 
0.0004
 
36 (21.3) 
129 (76.3) 
 
 
0.0006
Smoked 100 cigarettes 
  Never 
  Ever 
 
161 (50.9) 
154 (48.7)
 
 
81 (37.2) 
134 (61.5)
 
 
0.002
 
51 (30.2) 
114 (67.5) 
 
 
<.0001
Alcohol consumption 
  ≥ 1 drink in past year 
  No drinks in past year 
 
274 (86.7) 
40 (12.7)
 
 
177 (81.2) 
39 (17.9)
 
 
0.09
 
 
130 (76.9) 
35 (20.7) 
 
 
0.02
Eye color 
  Blue 
  Green 
  Hazel 
  Light brown 
  Dark brown 
 
94 (29.7) 
50 (16.1) 
52 (16.5) 
36 (11.4) 
80 (25.3)
  
87 (40.0) 
24 (11.0) 
48 (22.0) 
22 (10.1) 
35 (16.1)
 
 
 
 
 
0.009
 
69 (40.8) 
25 (14.8) 
31 (18.3) 
18 (10.7) 
22 (13.0) 
 
 
 
 
 
0.02
Hair Color 
  Black/Brown 
  Blonde/Red 
 
245 (77.5) 
70 (22.2)
  
152 (69.7) 
65 (29.8)
 
 
0.04
 
113 (66.9) 
53 (31.4) 
 
 
0.02
Color of un-tanned skin 
  White 
  Brown 
 
299 (94.9) 
15 (4.8)
 
 
209 (96.3) 
7 (3.2)
 
 
0.38
 
 
161 (95.3) 
6 (3.6) 
 
 
0.55
Cutaneous sensitivity to 
sunlight exposure 
  Sunburn with blisters 
  Sunburn w/o blisters 
  Mild sunburn/tan 
  Tan/no change color 
 
 
29 (9.2) 
96 (30.4) 
144 (45.6) 
44 (13.9)
  
 
33 (15.1) 
95 (43.6) 
65 (29.8) 
21 (9.6)
 
 
 
 
 
0.0001
 
 
22 (13.0) 
71 (42.0) 
50 (29.6) 
22 (13.0) 
 
 
 
 
 
0.005
Tanning ability to sunlight 
exposure 
  It is unable to tan 
  Tan if you work at it 
  It tans easily 
 
 
22 (7.0) 
103 (32.6) 
186 (58.9)
  
 
15 (6.9) 
93 (42.7) 
104 (47.7)
 
 
 
 
0.04
 
 
26 (15.4) 
77 (45.6) 
62 (37.6) 
 
 
 
 
<.0001
1p-value for chi-square test 
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Table 2.2. Associations between measures of patterns of sunlight exposure and basal cell and squamous cell carcinoma 
cases and controls  
 Controls  Basal cell carcinoma  Squamous cell carcinoma 
 (n=316)  (n=218)  (n=169) 
Variable n (%)  n (%) OR (95% CI)1 OR (95% CI)2  n (%) OR (95% CI)1 OR (95% CI)2 
Blistering Sunburn 
  No 
  Yes 
 
101 (32.3) 
212 (67.7) 
  
54 (25.0) 
162 (75.0) 
 
1.00 (reference) 
1.96 (1.27-3.03) 
 
1.00 (reference) 
1.56 (0.96-2.54) 
  
38 (23.0) 
127 (77.0) 
 
1.00 (reference) 
2.02 (1.22-3.33) 
 
1.00 (reference) 
1.24 (0.71-2.18) 
Job in sun ≥3 
months 
  No 
  Yes 
    # years with job 
      ≤10 
      >10 
 
 
227 (72.8) 
85 (27.2) 
 
57 (18.7) 
21 (6.9) 
  
 
120 (55.3) 
97 (44.7) 
 
47 (22.3) 
44 (20.9) 
 
 
1.00 (reference) 
1.38 (0.89-2.14) 
 
1.17 (0.70-1.94) 
2.14 (1.12-4.11) 
 
 
1.00 (reference) 
1.31 (0.81-2.12) 
 
1.07 (0.61-1.86) 
2.12 (1.05-4.27) 
  
 
86 (51.8) 
80 (48.2) 
 
44 (27.0) 
33 (20.2) 
 
 
1.00 (reference) 
1.73 (1.06-2.83) 
 
1.64 (0.94-2.86) 
2.54 (1.23-5.28) 
 
 
1.00 (reference) 
1.72 (0.99-2.97) 
 
1.64 (0.88-3.07) 
2.36 (1.07-5.20) 
Lifetime tanning bed 
use 
  Never used 
  1-10 times 
  >10 times 
 
 
209 (71.3) 
44 (15.0) 
40 (13.7) 
  
 
175 (82.5) 
25 (11.8) 
12 (5.7) 
 
 
1.00 (reference) 
0.99 (0.56-1.76) 
0.64 (0.30-1.36) 
 
 
1.00 (reference) 
0.99 (0.53-1.82) 
0.64 (0.30-1.36) 
  
 
127 (80.9) 
18 (11.5) 
12 (7.6) 
 
 
1.00 (reference) 
1.01 (0.52-1.98) 
1.67 (0.75-3.73) 
 
 
1.00 (reference) 
0.80 (0.38-1.71) 
1.85 (0.74-4.62) 
Apply SPF3 ≥15 
  Always/often 
  Sometimes 
  Rarely/never 
 
124 (39.6) 
98 (31.3) 
91 (29.1) 
  
82 (37.8) 
59 (27.2) 
76 (35.0) 
 
1.00 (reference) 
0.79 (0.50-1.26) 
0.83 (0.52-1.32) 
 
1.00 (reference) 
0.87 (0.52-1.45) 
0.93 (0.56-1.54) 
  
53 (32.5) 
56 (34.4) 
54 (33.1) 
 
1.00 (reference) 
0.83 (0.49-1.42) 
0.79 (0.46-1.36) 
 
1.00 (reference) 
0.86 (0.47-1.59) 
0.87 (0.48-1.60) 
Cumulative sunlight 
exposure 
  Low 
  Medium 
  High 
 
 
87 (32.3) 
92 (34.2) 
90 (33.5) 
 
 
 
 
52 (27.4) 
54 (28.4) 
84 (44.2) 
 
 
1.00 (reference) 
1.02 (0.61-1.69) 
1.37 (0.83-2.27) 
 
 
1.00 (reference) 
1.42 (0.81-2.50) 
1.88 (1.07-3.31) 
  
 
35 (22.7) 
57 (37.0) 
62 (40.3) 
 
 
1.00 (reference) 
1.49 (0.84-2.64) 
1.59 (0.88-2.87) 
 
 
1.00 (reference) 
2.36 (1.22-4.57) 
2.47 (1.25-4.91) 
Intermittent sunlight 
exposure 
  Low 
  Medium 
  High 
 
 
91 (33.8) 
84 (31.2) 
94 (34.9) 
  
 
80 (42.1) 
52 (27.4) 
58 (30.5) 
 
 
1.00 (reference) 
0.99 (0.60-1.64) 
1.15 (0.70-1.88) 
 
 
1.00 (reference) 
1.26 (0.72-2.22) 
1.23 (0.72-2.10) 
  
 
59 (38.3) 
46 (29.9) 
49 (31.8) 
 
 
1.00 (reference) 
1.25 (0.71-2.20) 
1.48 (0.85-2.58) 
 
 
1.00 (reference) 
1.58 (0.83-3.00) 
1.57 (0.83-2.94) 
                                                                                                               (Continued on next page) 
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Table 2.2 continued.  Associations between measures of patterns of sunlight exposure and basal cell and squamous cell carcinoma cases and 
controls 
 Controls  Basal cell carcinoma  Squamous cell carcinoma 
 (n=316)  (n=218)  (n=169) 
Variable n (%)  n (%) OR (95% CI)1 OR (95% CI)2  n (%) OR (95% CI)1 OR (95% CI)2 
Patterns by age at 
exposure   
  Teens 
    <1 hour 
    Continuous hours 
    Intermittent hours 
  Twenties 
    <1 hour 
    Continuous hours 
    Intermittent hours 
  Thirties 
    <1 hour 
    Continuous hours 
    Intermittent hours 
  Past 10 years 
    <1 hour 
    Continuous hours 
    Intermittent hours 
 
 
 
18 (6.0) 
151 (50.0) 
133 (44.0) 
 
34 (11.3) 
102 (33.9) 
165 (54.8) 
 
60 (20.5) 
85 (29.0) 
148 (50.5) 
 
63 (28.6) 
74 (33.6) 
83 (37.7) 
  
 
 
12 (6.0) 
113 (56.8) 
74 (37.2) 
 
18 (9.0) 
91 (45.5) 
91 (45.5) 
 
27 (13.6) 
79 (39.9) 
92 (46.5) 
 
52 (30.2) 
83 (48.3) 
37 (21.5) 
 
 
 
1.00 (reference) 
1.04 (0.45-2.41) 
1.08 (0.46-2.54) 
 
1.00 (reference) 
1.36 (0.68-2.71) 
1.30 (0.66-2.56) 
 
1.00 (reference) 
1.31 (0.72-2.40) 
1.38 (0.79-2.41) 
 
1.00 (reference) 
0.88 (0.51-1.52) 
0.57 (0.32-1.03) 
 
 
 
1.00 (reference) 
0.97 (0.38-2.48) 
1.10 (0.42-2.83) 
 
1.00 (reference) 
1.58 (0.75-3.36) 
1.56 (0.74-3.26) 
 
1.00 (reference) 
1.77 (0.90-3.49) 
2.09 (1.11-3.93) 
 
1.00 (reference) 
1.14 (0.62-2.12) 
0.67 (0.35-1.28) 
  
 
 
4 (2.5) 
96 (60.4) 
59 (37.1) 
 
11 (6.9) 
74 (46.5) 
74 (46.5) 
 
18 (11.3) 
69 (43.4) 
72 (45.3) 
 
49 (33.1) 
64 (43.2) 
35 (23.6) 
 
 
 
1.00 (reference) 
2.33 (0.69-7.90) 
2.26 (0.66-7.78) 
 
1.00 (reference) 
2.01 (0.86-4.67) 
2.11 (0.92-4.88) 
 
1.00 (reference) 
1.55 (0.77-3.10) 
1.47 (0.76-2.85) 
 
1.00 (reference) 
0.81 (0.46-1.42) 
0.60 (0.33-1.10) 
 
 
 
1.00 (reference) 
1.76 (0.48-6.47) 
1.86 (0.50-6.94) 
 
1.00 (reference) 
2.99 (1.19-7.48) 
3.15 (1.27-7.83) 
 
1.00 (reference) 
2.25 (1.02-4.94) 
1.95 (0.92-4.12) 
 
1.00 (reference) 
1.35 (0.69-2.64) 
0.93 (0.46-1.89) 
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age, gender, education, and history of ever smoking 
2OR and 95% CI adjusted for age, gender, education, history of ever smoking, ethnicity, eye and hair color, cutaneous sensitivity and tanning 
ability to sunlight exposure 
3SPF=sun protection factor 
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Table 2.3. Associations between measures of timing of sunlight exposure and basal cell and squamous cell carcinoma cases and controls 
 Controls  Basal cell carcinoma  Squamous cell carcinoma 
 (n=316)  (n=218)  (n=169) 
Variable n (%)  n (%) OR (95% CI)1 OR (95% CI)2  n (%) OR (95% CI)1 OR (95% CI)2 
# of moles on 
forearms 
  None 
  <10 
  ≥10 
 
 
220 (71.4) 
80 (26.0) 
8 (2.6) 
  
 
155 (71.8) 
53 (24.5) 
8 (3.7) 
 
 
1.00 (reference) 
0.84 (0.54-1.31) 
1.65 (0.57-4.77) 
 
 
1.00 (reference) 
0.65 (0.40-1.06) 
1.75 (0.55-5.61) 
  
 
115 (69.7) 
39 (23.6) 
11 (6.7) 
 
 
1.00 (reference) 
0.92 (0.56-1.52) 
3.27 (1.12-9.58) 
 
 
1.00 (reference) 
0.94 (0.54-1.64) 
2.69 (0.75-9.59) 
# of moles on entire 
body 
  None 
  <10 
  ≥10 
 
 
118 (39.1) 
147 (48.7) 
37 (12.3) 
  
 
79 (36.9) 
107 (50.0) 
28 (13.1) 
 
 
1.00 (reference) 
1.11 (0.73-1.67) 
1.18 (0.64-2.19) 
 
 
1.00 (reference) 
1.03 (0.66-1.60) 
1.06 (0.55-2.04) 
  
 
56 (34.1) 
76 (46.3) 
32 (19.5) 
 
 
1.00 (reference) 
1.15 (0.72-1.86) 
2.12 (1.11-4.06) 
 
 
1.00 (reference) 
1.22 (0.71-2.09) 
2.16 (1.03-4.52) 
Age at 1st sunburn 
  None 
  <10 years 
  10-20 years 
  >20 years 
 
101 (32.9) 
62 (20.2) 
108 (35.2) 
36 (11.7) 
  
54 (25.2) 
47 (22.0) 
84 (39.3) 
29 (13.6) 
 
1.00 (reference) 
1.97 (1.14-3.42) 
2.15 (1.32-3.52) 
1.71 (0.89-3.28) 
 
1.00 (reference) 
1.35 (0.73-2.49) 
1.73 (1.00-2.99) 
1.67 (0.83-3.37) 
  
38 (23.5) 
46 (28.4) 
65 (40.1) 
13 (8.0) 
 
1.00 (reference) 
2.25 (1.22-4.13) 
2.37 (1.34-4.21) 
0.96 (0.42-2.20) 
 
1.00 (reference) 
1.07 (0.53-2.15) 
1.62 (0.86-3.04) 
0.81 (0.33-2.01) 
Age at 1st tanning 
bed use 
  Never used 
  ≤20 years 
  >20 years 
 
 
209 (67.0) 
38 (12.2) 
65 (20.8) 
  
 
175 (80.3) 
20 (9.2) 
23 (10.6) 
 
 
1.00 (reference) 
1.09 (0.58-2.06) 
0.64 (0.64-1.12) 
 
 
1.00 (reference) 
1.10 (0.55-2.18) 
0.56 (0.30-1.05) 
  
 
127 (76.5) 
23 (13.9) 
16 (9.6) 
 
 
1.00 (reference) 
1.97 (1.01-3.85) 
0.77 (0.40-1.50) 
 
 
1.00 (reference) 
1.97 (0.91-4.27) 
0.78 (0.37-1.65) 
Daily sunlight 
exposure by age   
  Teens 
    Low 
    Medium 
    High 
  Twenties 
    Low 
    Medium 
    High 
  Thirties 
    Low 
    Medium 
    High 
  Past 10 years 
    Low 
    Medium 
    High 
 
 
 
63 (20.9) 
104 (34.4) 
135 (44.7) 
 
121 (40.2) 
114 (37.9) 
66 (21.9) 
 
152 (51.9) 
103 (35.2) 
38 (13.0) 
 
126 (57.3) 
65 (29.5) 
29 (13.2) 
  
 
 
27 (13.6) 
68 (34.2) 
104 (52.3) 
 
62 (31.0) 
79 (39.5) 
59 (29.5) 
 
87 (43.9) 
63 (31.8) 
48 (24.2) 
 
76 (44.2) 
59 (34.3) 
37 (21.5) 
 
 
 
1.00 (reference) 
1.28 (0.71-2.30) 
1.38 (0.78-2.43) 
 
1.00 (reference) 
1.20 (0.77-1.88) 
1.22 (0.73-2.31) 
 
1.00 (reference) 
0.90 (0.58-1.39) 
1.20 (0.68-2.10) 
 
1.00 (reference) 
1.05 (0.64-1.74) 
1.41 (0.74-2.68) 
 
 
 
1.00 (reference) 
1.18 (0.62-2.25) 
1.47 (0.78-2.77) 
 
1.00 (reference) 
1.35 (0.82-2.21) 
1.31 (0.75-2.31) 
 
1.00 (reference) 
0.98 (0.60-1.58) 
1.28 (0.69-2.36) 
 
1.00 (reference) 
1.15 (0.66-2.01) 
1.62 (0.79-3.30) 
  
 
 
21 (13.2) 
55 (34.6) 
83 (52.2) 
 
53 (33.3) 
51 (32.1) 
55 (34.6) 
 
64 (40.3) 
62 (39.0) 
33 (20.8) 
 
80 (54.1) 
40 (27.0) 
28 (18.9) 
 
 
 
1.00 (reference) 
1.24 (0.64-2.42) 
1.43 (0.75-2.73) 
 
1.00 (reference) 
0.82 (0.49-1.37) 
1.40 (0.80-2.44) 
 
1.00 (reference) 
1.08 (0.66-1.75) 
1.15 (0.61-2.18) 
 
1.00 (reference) 
0.77 (0.45-1.31) 
1.16 (0.59-2.25) 
 
 
 
1.00 (reference) 
0.94 (0.45-1.97) 
1.40 (0.68-2.89) 
 
1.00 (reference) 
0.97 (0.54-1.73) 
1.56 (0.83-2.91) 
 
1.00 (reference) 
1.36 (0.78-2.37) 
1.30 (0.63-2.68) 
 
1.00 (reference) 
1.13 (0.61-2.10) 
1.57 (0.73-3.36) 
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age, gender, education, and history of ever smoking 
2OR and 95% CI adjusted for age, gender, education, history of ever smoking, cutaneous sensitivity and tanning ability to sunlight exposure 
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CHAPTER 3: 
SUNLIGHT EXPOSURE AND CUTANEOUS HUMAN PAPILLOMAVIRUS  
IN NON-MELANOMA SKIN CANCER 
 
Abstract 
Non-melanoma skin cancer (NMSC), comprised of basal cell (BCC) and 
squamous cell carcinoma (SCC), is the most common cancer in Caucasians.  Ultraviolet 
radiation (UVR) exposure is the most important environmental risk factor for both BCC 
and SCC development.  Recently, epidemiologic studies have demonstrated that 
cutaneous human papillomavirus (HPV) infection may also be a risk factor for 
developing NMSC.  However, the pathway by which cutaneous HPV is associated with 
NMSC remains unclear.  It is hypothesized that UVR exposure may interact 
synergistically with cutaneous HPV in NMSC development.  To investigate differences in 
sunlight-associated BCC and SCC risk by genus-specific cutaneous HPV serostatus, a 
clinic based case-control study was conducted.  NMSC cases included patients with 
histologically confirmed BCC (n=204) and SCC (n=156) diagnoses recruited from a 
university dermatology clinic and controls were participants with no history of cancer and 
screened negative for current skin cancer (n=297).  NMSC cases were more likely to be 
seropositive for cutaneous HPV antibodies compared to controls.  Compared to tanning, 
having a propensity to sun burn (p=0.006), or poor tanning ability (p=0.003) were 
significantly associated with a higher seroprevalence to genus beta HPV types within 
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SCC cases.  Statistically significant interactions were observed between poor tanning 
ability and genus-specific seropositivity with NMSC.  Specifically, the associations 
between poor tanning ability and BCC (pinteraction=0.02) and SCC (pinteraction=0.01) were 
significantly stronger among individuals that were seropositive for antibodies to genus 
alpha HPV types.  Similarly, the association between poor tanning ability and SCC was 
stronger among those seropositive for genus beta HPV types (pinteraction=0.001).  In 
conclusion, evidence from the current study supports the hypothesis that cutaneous 
HPV infection may play a potential role in the association between UVR and NMSC.  
Introduction 
Non-melanoma skin cancer (NMSC), comprised of basal (BCC) and squamous 
(SCC) cell carcinomas, is the most common cancer in Caucasians, with more than one 
million new cases diagnosed annually in the United States alone(1).  Constitutional 
factors, including light eye, hair, and skin color, as well as older age, male sex, and 
immunosuppression(12) have been identified as risk factors for BCC and SCC.  
Ultraviolet radiation (UVR) exposure has been implicated in the etiology of skin cancer 
and is considered the most important environmental risk for both BCC and SCC 
development.   
Several lines of evidence suggest that UVR exposure may play a synergistic role 
along with cutaneous human papillomavirus (HPV) infection in the development of 
cutaneous NMSC.  HPVs belong to a large family of more than 100 genotypes, including 
types that infect cutaneous epithelia identified from genera alpha, beta, gamma, mu, and 
nu(50).  Presence of antibodies against cutaneous HPV types has been associated with 
SCC in several epidemiologic studies(29, 30, 34, 71-73);  however, results from 
epidemiologic studies of cutaneous HPV and BCC are less consistent(29, 30, 34, 71, 72)  
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and fewer in number.   UV-B radiation has been shown to stimulate the promoter activity 
of HPV 5 and 8(39). In turn, the E6 and/or E7 proteins of genus beta HPV types have 
been shown to inhibit UVR-induced apoptosis through p53-independent pathways(45, 
46), reduced capacity to repair UVR-induced mutations(43), and  alter the regulation of 
UVR-activated cell cycle checkpoints.   
The goal of the current study was to investigate the potential modifying effects of 
cutaneous HPV seroreactivity on the associations between sunlight related factors and 
BCC and SCC. 
Materials and Methods 
Study design and population 
  
To investigate differences in sunlight-associated BCC and SCC risk by 
cutaneous HPV seroreactivity, a clinic-based case-control analysis was conducted.  
Study procedures have been described previously(59).  Participants were recruited from 
the Dermatology (D) and Family Medicine (FM) clinics at the University of South Florida 
(USF), as well as Moffitt’s Lifetime Cancer Screening and Prevention (LCS) clinic.  
Eligible cases were patients, ages 18-80 years, diagnosed with a histologically-
confirmed BCC or SCC.  Controls were patients who reported no history of any type of 
skin cancer at the time of study recruitment and screened negative for skin cancer as 
determined by a full body skin cancer screening exam conducted by a nurse practitioner.   
Participation rates for the USF-D, the USF-FM, and LCS clinics were 80%, 47%, and 
65%, respectively.  No significant differences in age or gender were observed between 
study participants and non-participants from the USF-D clinic.  Significant differences in 
age, but not gender, were observed between study participants and non-participants 
from the USF-FM and LCS clinics.        
31 
 
All study participants were asked to complete a self-administered questionnaire 
including questions on demographic, constitutional characteristics, life-style factors, and 
measures of sunlight exposure, and to provide a blood sample for cutaneous HPV 
antibody measurement.  A total of 204 BCC, 156 SCC, and 297 controls had available 
questionnaire data and cutaneous HPV antibody results.  Participants that reported a 
race other than white or had missing data on race were excluded from the current study 
analysis.  All participants provided written informed consent.  All study procedures were 
approved by the institutional review board at the University of South Florida. 
 
Measurement of antibodies to cutaneous human papillomavirus types 
 
At the time of study enrollment, blood was drawn using a sterile needle into 
serum separator tubes with clot activators.  Following centrifugation, serum was 
aliquoted into cryovials and stored at -80oC until being shipped on dry ice to Dr. Pawlita’s 
laboratory at the German Cancer Research Center (Deutsches Krebsforschungzentrum, 
(DKFZ)), for analysis.  Samples were analyzed for antibodies to the major capsid protein 
L1 for 7 types in genus alpha (2, 3, 7, 10, 27, 57, 77), 17 types in genus beta (5, 8, 9, 15, 
17, 20, 23, 24, 25, 36, 38, 49, 75, 76, 92, 96, 107), 8 types in genus gamma (4, 48, 50, 
65, 88, 95, 101, 103), and 1 type in both genus mu (1) and genus nu (41), using a  
detection method based on Glutathione-S-Transferase (GST) capture ELISA as 
described in Sehr et al.(74, 75) in combination with fluorescent bead technology 
(Luminex) as recently described(76).  Briefly, full-length viral proteins were expressed in 
bacteria in fusion with an N-terminal glutathione S-transferase (GST) domain. 
Glutathione-crosslinked to casein was coupled to fluorescence-labeled polystyrol beads 
and GST fusion proteins were affinity-purified on the beads directly in a one-step 
procedure. Bead types of different color and carrying different antigens were mixed and 
incubated with human sera.  Antibody bound to the beads via the viral antigens was 
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stained by biotinylated anti-human-Ig and streptavidin-phycoerythrin. Beads were 
analyzed in a luminex analyzer that identifies the bead color - and thus the antigen 
carried by the bead – and quantified the antibody bound to viral antigen via the median 
phycoerythrin fluorescence intensity of at least 100 beads of the same internal color.  
Cutoff points to define seropositivity were applied as described elsewhere(29, 35). 
Statistical analysis 
Differences in the distributions of demographic and skin cancer risk factors, as 
well as genus-specific HPV seroreactivity between NMSC cases and controls were 
tested using the chi-square test.  The sunlight exposure factors included cutaneous 
sensitivity to one hour of sunlight exposure for the first time without sunscreen 
(experience a sunburn with or without blistering, a mild sunburn that turns to a tan, 
tanning or no change in skin color); tanning ability from repeated sunlight exposure (it is 
unable to tan, it can tan if you work at it, it tans easily); history of blistering sunburn 
(yes/no); and cumulative sunlight exposure in early life (low, high).  To measure 
cumulative sunlight exposure in early life (i.e. <30 years of age), a median value was 
applied to each category of hours of sunlight exposure (<1 hour=0.5; 1-2 hours=1.5; 3-4 
hours=3.5; 5-6 hours=5.5) experienced on a weekday and weekend day during the 
summer in different time periods (i.e. one’s teens, twenties, and thirties).  The median 
values applied to weekday and weekend day hours of exposure were first summed for 
each individual age period and then summed across the three age periods and divided 
into two categories: low and high.  Analyses involving cumulative sunlight exposure in 
early life were restricted to participants who were ≥40 years of age. 
Logistic regression models were used to calculate odds ratios (OR) and 95% 
confidence intervals (CI) for the associations between sun-related factors and BCC and 
SCC.  Confounding by constitutional, demographic, lifestyle and skin cancer risk factors 
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was assessed, and with the exception of age and gender, inclusion of additional co-
factors did not alter the calculated estimates by more than 10%, thus final models 
included only age and gender as covariates. 
Participants were classified as HPV-seropositive or HPV-seronegative for 
antibodies to each individual cutaneous HPV type measured based on HPV type-specific 
cut points assigned.  Cutaneous HPV types were then grouped by genus.  Overall 
genus-specific seropositivity was calculated as the proportion of participants who tested 
positive for antibodies to at least one of the types in that genus.  Genus-specific 
seropositive participants were compared to participants that tested negative for all types 
in that genus.  The chi-square test was used to describe differences in the distributions 
of genus-specific HPV seropositivity across sun-related factors among cases and 
controls. The associations between sun-related factors and BCC and SCC were 
stratified by genus-specific HPV serostatus (seropositive, seronegative), and stratum-
specific OR and corresponding 95% CIs were estimated.  Statistical significance of 
multiplicative interactions between genus-specific seroreactivity and sun-related factors 
as they related to BCC and SCC was tested by placing an interaction term for the 
product of genus-specific seroreactivity and the sun-related factors in the logistic 
regression models.  A p-value of <0.05 for the beta coefficient corresponding to the 
interaction term was considered statistically significant.   All analyses were conducted 
using the SAS statistical software package (version 9.2; SAS Institute). 
Results 
 Compared to controls, NMSC cases were significantly more likely to be male, 
older in age, more likely to burn from sunlight exposure, and exhibit diminished ability to 
tan (Table 1).   Additionally, SCC cases reported higher levels of cumulative sunlight 
exposure (p=0.03) compared to controls (Table 1).  Seroprevalence was highest for 
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cutaneous HPV types in genus beta for SCC cases (73.1%) and controls (60.3%), 
followed by genus gamma (62.8% and 52.2% in SCC cases and controls, respectively) 
(Table 1).  BCC cases were equally likely as controls to be seropositive for HPV types in 
genus beta (68.1%) and genus gamma (68.6%).  Statistically significant case-control 
differences in HPV seropositivity were observed for HPV types in genus alpha and BCC 
(p=0.01), in genus beta and SCC (p=0.01), and in genus gamma and BCC (p=0.0002) 
as well as SCC (p=0.03).   
  Associations between sunlight related factors with BCC and SCC with 
adjustment for age and sex are presented in Table 2.  Cutaneous sensitivity, specifically 
experiencing a sunburn when exposed to at least one hour of sunlight, poor tanning 
ability, and history of blistering sunburn were statistically significantly associated with 
both BCC and SCC.  Cumulative sunlight exposure was associated with SCC; similar 
associations were not observed for BCC. 
Differences in genus-specific HPV seropositivity by sun-related factors within 
BCC/SCC case groups and the control group are presented in Table 3.  Among SCC 
cases, seroprevalence for HPV types in genus beta was significantly associated with a 
propensity to burn when exposed to sunlight (p=0.006) and inability to tan after repeated 
sunlight exposure (p=0.003) (Table 3).  Additionally, among controls, seroprevalence for 
the single HPV type in genus mu was significantly associated with a propensity to burn 
when exposed to sunlight (p=0.02) (Table 3).   
Given that cutaneous sensitivity to sunlight exposure and tanning ability were 
associated with HPV seropositivity, associations between these two sun-related factors 
and BCC/SCC were stratified by genus-specific HPV serostatus to investigate potential 
effect modification.  Associations between propensity to sunburn and BCC/SCC were 
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relatively similar across categories of cutaneous HPV serostatus, with none of the 
interaction terms being statistically significant (Table 4).  Poor tanning ability was 
associated with statistically significant increased risks of BCC (OR=4.71, 95% CI=2.29-
9.66) and SCC (OR=15.60, 95% CI=5.40-45.1) among those who were seropositive to 
genus alpha HPV types, whereas more modest risks of BCC (OR=1.48, 95% CI=0.88-
2.48) and SCC (OR=2.53, 95% CI=1.43-4.46) were observed among those who were 
seronegative to HPV types in genus alpha.  Both interactions were statistically significant 
(p=0.02 for BCC, p=0.01 for SCC).  Additionally, the association between poor tanning 
ability and SCC was significantly greater among genus beta HPV-seropositive 
individuals (OR=6.86, 95% CI=3.68-12.80) than seronegative individuals (OR=1.39, 95% 
CI=0.59-3.31) (p for interaction=0.001) (Table 4).  No significant interactions were 
observed between sun-related factors and seropositivity for HPV types in genera 
gamma, mu or nu in relation to either BCC or SCC. 
Discussion 
A case-control study was conducted to investigate the potential modifying effects 
of cutaneous HPV seroreactivity on the associations between skin cancer risk factors 
and basal cell (BCC) and squamous cell (SCC) carcinomas of the skin.  With the 
exception of cumulative sunlight exposure and BCC, all sun-related measures were 
associated with BCC and SCC in the current study population.  The associations 
between poor tanning ability and BCC/SCC were significantly greater among those who 
were seropositive for HPV types in genus alpha, and the association between poor 
tanning ability and SCC was significantly greater among those who were seropositive to 
HPV types in genus beta. 
It is hypothesized that UVR exposure may interact synergistically with cutaneous 
HPV in NMSC development, in which case one  would expect to observe interactions 
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between cutaneous HPV seropositivity and sun-related factors in relation to  BCC and 
SCC.  Tanning ability, specifically poor tanning ability, was the only sun-related factor 
measured that demonstrated statistically significant multiplicative interactions with 
cutaneous HPV seropositivity in BCC and SCC in the current study population.  Two 
population based case-control studies from New Hampshire(34, 72) investigated 
modifying effects of genus beta HPV seroreactivity on the associations between SCC 
and cutaneous sensitivity to sunlight exposure and the number of lifetime painful 
sunburns, but no statistically significant interactions were observed.  A multi-center 
study(77) observed a statistically significant interaction between lighter skin photo-type 
and genus beta seropositivity in SCC among residents of the Netherlands.  Similar 
observations were not observed among residents of Italy and Australia(77).  Interactions 
between genus beta seroreactivity and the number of sunburns before age 20 and the 
average daily sun exposure in SCC were also investigated; no statistically significant 
interactions were observed among residents from any site(77).  Differences across the 
study populations may be explained by varying levels of UVR exposure by geographic 
regions as well as differences in the underlying characteristics of the study populations, 
including age and sex.  Additionally, direct comparisons between reported observations 
across study populations have been based on different numbers of beta-HPV types 
analyzed.  This may explain differences in the observed interactions between sunlight 
related factors and genus beta HPV seroreactivity in SCC.   
The proposed study has some limitations.  Case-control studies are often subject 
to recall bias because cases tend to think about their exposures more carefully as they 
might relate to their current cancer diagnosis.  However, the participants did not know 
their HPV serostatus at the time of questionnaire completion, and therefore, the 
interaction results should not be subject to recall bias.  Sample sizes were small limiting 
37 
 
stratified analyses and the ability to detect statistically significant interactions.  Despite 
the limitations of the proposed study, several strengths should also be noted.  The 
current study presents cutaneous HPV genus-specific associations outside of genus 
alpha and beta in a U.S. population.  It is the first study to investigate interaction effects 
between genus-specific HPV seropositivity and multiple measures of sunlight exposure 
as they relate to both BCC and SCC in a U.S. population.  The use of a multiplexed 
assay to assess seropositivity to multiple cutaneous HPV types is a great strength of the 
proposed study.  Dr. Pawlita’s laboratory has been used in most of the sero-
epidemiologic studies of cutaneous HPV published to date(29, 34-37, 78), including the 
two studies published from the U.S. in New Hampshire(34, 72).  This allowed us to 
directly compare our results to those observed in New Hampshire where levels of UV 
radiation exposure are significantly lower compared to Florida.   
UV radiation exposure is the most important environmental risk factor for NMSC, 
and given that the incidence of NMSC is increasing despite the increased use of 
sunscreen products, there is a need to identify cofactors that may interact with UV 
radiation exposure to increase the risk of NMSC so novel prevention strategies can be 
developed.  Epidemiologic studies have demonstrated a potential role for cutaneous 
HPV infections in NMSC development(29, 30, 34, 71-73), and accumulating evidence 
suggests that cutaneous HPV may interact synergistically with UV radiation exposure in 
NMSC development.  However, additional studies are needed, including those that 
measure infection with HPV types in multiple genera.  Identifying how cutaneous HPV 
infections may influence sunlight-associated risks of NMSC may lead to improved 
characterization of high-risk individuals and aid in the development of novel prevention 
strategies. 
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Table 3.1.  Demographic and skin cancer risk factors in basal cell and squamous cell 
carcinoma cases and controls 
  Controls BCC  SCC 
  (n=297) (n=204)  (n=156) 
Variable  n (%) n (%) p1  n (%) p1
Age (years) mean (S.D.)  55.2 (11.7) 62.6 (12.0) <.0001  64.7 (9.8) <.0001
Age (years) 
    18-39 
    40-49 
    50-59 
    60-69 
    70-80 
  
28 (9.4) 
54 (18.2) 
104 (35.0) 
83 (28.0) 
28 (9.4)
 
7 (3.4) 
24 (11.8) 
42 (20.6) 
60 (29.4) 
71 (34.8)
 
 
 
 
 
<.0001
  
3 (1.9) 
10 (6.4) 
28 (18.0) 
63 (40.4) 
52 (33.3) 
 
 
 
 
 
<.0001
Gender 
    Male 
    Female 
  
111 (37.4) 
186 (62.6)
 
123 (60.3) 
81 (39.7)
 
 
<.0001
  
100 (64.1) 
56 (35.9) 
 
 
<.0001
Cutaneous sensitivity 
    Mild sunburn turn to      
     tan/tan 
    Sunburn/blistering 
  
177 (60.0) 
 
118 (40.0)
 
80 (40.0) 
 
120 (60.0)
 
 
 
<.0001
  
65 (42.8) 
 
87 (57.2) 
 
 
 
0.001
Tanning ability 
    Tans easily 
    Tan if work at it/ 
     unable to tan 
  
173 (59.3) 
 
119 (40.8)
 
96 (48.5) 
 
102 (51.5)
 
 
 
0.02
  
56 (36.8) 
 
96 (63.2) 
 
 
 
<.0001
History of blistering 
sunburn 
    No 
    Yes 
  
 
92 (31.3) 
202 (68.7)
 
 
52 (25.7) 
150 (74.3)
 
 
 
0.18
  
 
35 (23.0) 
117 (77.0) 
 
 
 
0.07
Cumulative sunlight 
exposure 
    Low 
    High 
  
 
82 (32.5) 
170 (67.5)
 
 
51 (28.7) 
127 (71.4)
 
 
 
0.39
  
 
31 (22.0) 
110 (78.0) 
 
 
 
0.03
Genus Alpha 
    Negative 
    Positive 
  
193 (65.0) 
104 (35.0)
  
109 (53.4) 
95 (46.6)
 
 
0.01
  
96 (61.5) 
60 (38.5) 
 
 
0.47
Genus Beta 
    Negative 
    Positive 
  
118 (39.7) 
179 (60.3)
  
65 (31.9) 
139 (68.1)
 
 
0.07
  
42 (26.9) 
114 (73.1) 
 
 
0.01
Genus Gamma 
    Negative 
    Positive 
  
142 (47.8) 
155 (52.2)
  
64 (31.4) 
140 (68.6)
 
 
0.0002
  
58 (37.2) 
98 (62.8) 
 
 
0.03
Genus Mu 
    Negative 
    Positive 
  
202 (68.0) 
95 (32.0)
  
126 (61.8) 
78 (38.2)
 
 
0.15
  
94 (60.3) 
62 (39.7) 
 
 
0.10
Genus Nu 
    Negative 
    Positive 
  
263 (88.6) 
34 (11.4)
  
180 (88.2) 
24 (11.8)
 
 
0.91
  
136 (87.2) 
20 (12.8) 
 
 
0.67
1p-value for chi-square test 
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Table 3.2. Associations between sunlight related factors and basal cell and squamous cell 
carcinoma cases and controls 
  Controls  Basal cell carcinoma  Squamous cell carcinoma 
  (n=297)  (n=204)  (n=156) 
Sunlight related factor  n (%)  n (%) OR (95% CI)1  n (%) OR (95% CI)1 
Cutaneous sensitivity 
  Mild sunburn turn to tan/tan 
  Sunburn/blistering 
 
177 (60.0)
118 (40.0)
80 (40.0)
120 (60.0)
 
1.00 (reference) 
2.75 (1.84-4.11)
 
65 (42.8)
87 (57.2)
 
1.00 (reference) 
2.39 (1.53-3.74) 
Tanning ability 
  Tans easily 
  Tan if work at it/unable to tan 
 
173 (59.3)
119 (40.8)
96 (48.5)
102 (51.5)
 
1.00 (reference) 
2.23 (1.48-3.34)
 
56 (36.8)
96 (63.2)
 
1.00 (reference) 
4.09 (2.52-6.64) 
History of blistering sunburn 
  No 
  Yes 
 
92 (31.3)
202 (68.7)
52 (25.7)
150 (74.3)
 
1.00 (reference) 
1.59 (1.04-2.46)
 
35 (23.0)
117 (77.0)
 
1.00 (reference) 
1.79 (1.08-2.96) 
Cumulative sunlight exposure 
  Low 
  High 
 
82 (32.5)
170 (67.5)
51 (28.7)
127 (71.4)
 
1.00 (reference) 
1.21 (0.77-1.89)
 
31 (22.0)
110 (78.0)
 
1.00 (reference) 
1.85 (1.08-3.15) 
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and gender 
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 Table 3.3a.  Distribution of cutaneous sensitivity to sunlight exposure by genus-specific HPV seropositivity 
 in basal cell and squamous cell carcinoma cases and controls 
 % Genus-specific HPV seropositive 
 Controls (n=297)  BCC (n=204)  SCC (n=156) 
Cutaneous sensitivity n (%1) p2  n (%1) p2  n (%1) p2 
  
 Alpha   Alpha   Alpha  
Mild sunburn to tan/tan 
Sunburn/blistering 
60 (33.9) 
43 (36.4) 
 
0.65 
 37 (46.3) 
57 (47.5) 
 
0.86 
 24 (36.9) 
35 (40.2)  
 
0.68 
  
 Beta   Beta   Beta  
Mild sunburn to tan/tan 
Sunburn/blistering 
103 (58.2) 
75 (63.6) 
 
0.36 
 52 (65.0) 
83 (69.2) 
 
0.54 
 40 (61.5) 
71 (81.6) 
 
0.006 
  
 Gamma   Gamma   Gamma  
Mild sunburn to tan/tan 
Sunburn/blistering 
89 (50.3) 
66 (55.9) 
 
0.34 
 58 (72.5) 
80 (66.7) 
 
0.38 
 41 (63.1) 
54 (62.1) 
 
0.90 
  
 Mu   Mu   Mu  
Mild sunburn to tan/tan 
Sunburn/blistering 
48 (27.1) 
47 (39.8) 
 
0.02 
 28 (35.0) 
49 (40.8) 
 
0.41 
 24 (36.9) 
36 (41.4) 
 
0.58 
  
 Nu   Nu   Nu  
Mild sunburn to tan/tan 
Sunburn/blistering 
16 (9.0) 
18 (15.3) 
 
0.10 
 10 (12.5) 
14 (11.7) 
 
0.86 
 10 (15.4) 
10 (11.5) 
 
0.48 
 1Percent includes the proportion of individuals that are HPV seropositive for types within a given genus 
 2chi-square p-value
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 Table 3.3b.  Distribution of tanning ability to sunlight exposure by genus-specific HPV seropositivity 
 in basal cell and squamous cell carcinoma cases and controls 
 % Genus-specific HPV seropositive 
 Controls (n=297)  BCC (n=204)  SCC (n=156) 
Tanning ability n (%1) p2  n (%1) p2  n (%1) p2 
  
 Alpha   Alpha   Alpha  
Tans easily 
If work at it/unable to tan 
67 (38.7) 
35 (29.4) 
 
0.10 
 41 (42.7) 
52 (51.0) 
 
0.24 
 19 (33.9) 
40 (41.7) 
 
0.35 
  
 Beta   Beta   Beta  
Tans easily 
If work at it/unable to tan 
107 (61.9) 
69 (58.0) 
 
0.51 
 64 (66.7) 
71 (69.6) 
 
0.66 
 33 (58.9) 
78 (81.3) 
 
0.003 
  
 Gamma   Gamma   Gamma  
Tans easily 
If work at it/unable to tan 
90 (52.0) 
64 (53.8) 
 
0.77 
 61 (63.5) 
76 (74.5) 
 
0.09 
 32 (57.1) 
62 (64.6) 
 
0.36 
  
 Mu   Mu   Mu  
Tans easily 
If work at it/unable to tan 
56 (32.4) 
38 (31.9) 
 
0.94 
 34 (35.4) 
42 (41.2) 
 
0.41 
 17 (30.4) 
43 (44.8) 
 
0.08 
  
 Nu   Nu   Nu  
Tans easily 
If work at it/unable to tan 
19 (11.0) 
14 (11.8) 
 
0.84 
 12 (12.5) 
12 (11.8) 
 
0.87 
 5 (8.9) 
15 (15.6) 
 
0.24 
 1Percent includes the proportion of individuals that are HPV seropositive for types within a given genus 
 2chi-square p-value 
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Table 3.3c.  Distribution of history of blistering sunburn by genus-specific HPV seropositivity in basal cell and  
squamous cell carcinoma cases and controls 
 % Genus-specific HPV seropositive 
 Controls (n=297)  BCC (n=204)  SCC (n=156) 
Blistering sunburn n (%1) p2  n (%1) p2  n (%1) p2 
  
 Alpha   Alpha   Alpha  
No 
Yes 
33 (35.9) 
70 (34.7) 
 
0.84 
 24 (46.2) 
71 (47.3) 
 
0.88 
 11 (31.4) 
47 (40.2) 
 
0.35 
  
 Beta   Beta   Beta  
No 
Yes 
50 (54.4) 
128 (63.4) 
 
0.14 
 37 (71.2) 
101 (67.3) 
 
0.61 
 25 (71.4) 
85 (72.7) 
 
0.89 
  
 Gamma   Gamma   Gamma  
No 
Yes 
42 (45.7) 
112 (55.5) 
 
0.12 
 36 (69.2) 
103 (68.7) 
 
0.94 
 23 (65.7) 
71 (60.7) 
 
0.59 
  
 Mu   Mu   Mu  
No 
Yes 
24 (26.1) 
69 (34.2) 
 
0.17 
 14 (26.9) 
64 (42.7) 
 
0.05 
 12 (34.3) 
49 (41.9) 
 
0.42 
  
 Nu   Nu   Nu  
No 
Yes 
10 (29.4) 
24 (11.9) 
 
0.80 
 4 (7.7) 
20 (13.3) 
 
0.28 
 4 (11.4) 
16 (13.7) 
 
0.73 
1Percent includes the proportion of individuals that are HPV seropositive for types within a given genus 
2chi-square p-value
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Table 3.3d.  Distribution of levels of cumulative sunlight exposure by genus-specific HPV seropositivity 
in basal cell and squamous cell carcinoma cases and controls 
 % Genus-specific HPV seropositive 
 Controls (n=297)  BCC (n=204)  SCC (n=156) 
Cumulative sun exposure n (%1) p2  n (%1) p2  n (%1) p2 
  
 Alpha   Alpha   Alpha  
Low 
High 
27 (32.9) 
50 (29.4) 
 
0.57 
 19 (37.3) 
63 (49.6) 
 
0.14 
 16 (51.6) 
37 (33.6) 
 
0.07 
  
 Beta   Beta   Beta  
Low 
High 
46 (56.1) 
101 (59.4) 
 
0.62 
 34 (28.3) 
86 (67.7) 
 
0.89 
 22 (71.0) 
84 (76.4) 
 
0.54 
  
 Gamma   Gamma   Gamma  
Low 
High 
37 (45.1) 
91 (53.5) 
 
0.21 
 35 (68.6) 
88 (69.3) 
 
0.93 
 22 (71.0) 
67 (60.9) 
 
0.31 
  
 Mu   Mu   Mu  
Low 
High 
32 (39.0) 
50 (29.4) 
 
0.13 
 21 (41.2) 
50 (39.8) 
 
0.82 
 11 (35.5) 
48 (43.6) 
 
0.42 
  
 Nu   Nu   Nu  
Low 
High 
11 (13.4) 
16 (9.4) 
 
0.34 
 8 (15.7) 
14 (11.0) 
 
0.39 
 2 (6.5) 
17 (15.5) 
 
0.19 
1Percent includes the proportion of individuals that are HPV seropositive for types within a given genus 
2chi-square p-value 
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  Table 3.4.  Associations between sunlight related factors and basal cell and squamous cell carcinoma cases by     
  genus-specific human papillomavirus serostatus 
  Basal cell carcinoma (n=204)   Squamous cell carcinoma (n=156)  
  HPV serostatus   HPV serostatus  
  Positive Negative   Positive Negative  
Sunlight factor  OR (95% CI)1 OR (95% CI)1 p2  OR (95% CI)1 OR (95% CI)1 p2 
Cutaneous sensitivity         
  Alpha   Alpha  
Mild sunburn turn to tan/tan 
Sunburn/blistering 
 1.00 (reference) 
2.39 (1.28-4.47) 
1.00 (reference) 
2.94 (1.74-4.99) 
 
0.55  
1.00 (reference) 
2.52 (1.17-5.42) 
1.00 (reference) 
2.32 (1.33-4.02) 
 
0.88 
  Beta   Beta  
Mild sunburn turn to tan/tan 
Sunburn/blistering 
 1.00 (reference) 
2.63 (1.60-4.35) 
1.00 (reference) 
2.90 (1.48-5.69) 
 
0.82  
1.00 (reference) 
2.75 (1.60-4.75) 
1.00 (reference) 
1.38 (0.60-3.18) 
 
0.14 
  Gamma   Gamma  
Mild sunburn turn to tan/tan 
Sunburn/blistering 
 1.00 (reference) 
2.05 (1.24-3.37) 
1.00 (reference) 
4.68 (2.30-9.52) 
 
0.08  
1.00 (reference) 
1.95 (1.09-3.50) 
1.00 (reference) 
3.02 (1.50-6.12) 
 
0.35 
  Mu   Mu  
Mild sunburn turn to tan/tan 
Sunburn/blistering 
 1.00 (reference) 
2.02 (1.05-3.87) 
1.00 (reference) 
3.19 (1.90-5.36) 
 
0.51  
1.00 (reference) 
1.75 (0.83-3.68) 
1.00 (reference) 
2.88 (1.62-5.13) 
 
0.32 
  Nu   Nu  
Mild sunburn turn to tan/tan 
Sunburn/blistering 
 1.00 (reference) 
1.23 (0.40-3.76) 
1.00 (reference) 
3.17 (2.05-4.90) 
 
0.12  
1.00 (reference) 
0.90 (0.26-3.11) 
1.00 (reference) 
2.77 (1.71-4.49) 
 
0.10 
  1Odds ratios (OR) and 95% confidence (CI) intervals adjusted for age and gender 
  2p-value for interaction between genus specific HPV seroreactivity and sunlight related factor 
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  Table 3.4 continued.  Associations between sunlight related factors and basal cell and squamous cell carcinoma   
  cases by genus-specific human papillomavirus serostatus 
  Basal cell carcinoma (n=204)   Squamous cell carcinoma (n=156)  
  HPV serostatus   HPV serostatus  
  Positive Negative   Positive Negative  
Sunlight factor  OR (95% CI)1 OR (95% CI)1 p2  OR (95% CI)1 OR (95% CI)1 p2 
Tanning Ability         
  Alpha   Alpha  
Tans easily 
Tan if work at it/unable to tan  
1.00 (reference) 
4.71 (2.29-9.66) 
1.00 (reference) 
1.48 (0.88-2.48) 
 
0.02  
1.00 (reference) 
15.6 (5.40-45.1) 
1.00 (reference) 
2.53 (1.43-4.46) 
 
0.01 
  Beta   Beta  
Tans easily 
Tan if work at it/unable to tan  
1.00 (reference) 
2.94 (1.73-4.98) 
1.00 (reference) 
1.44 (0.75-2.78) 
 
0.13  
1.00 (reference) 
6.86 (3.68-12.8) 
1.00 (reference) 
1.39 (0.59-3.31) 
 
0.001
  Gamma   Gamma  
Tans easily 
Tan if work at it/unable to tan  
1.00 (reference) 
2.50 (1.49-4.20) 
1.00 (reference) 
1.67 (0.85-3.29) 
 
0.30  
1.00 (reference) 
4.42 (2.33-8.38) 
1.00 (reference) 
3.65 (1.72-7.76) 
 
0.61 
  Mu   Mu  
Tans easily 
Tan if work at it/unable to tan  
1.00 (reference) 
2.52 (1.28-4.95) 
1.00 (reference) 
2.10 (1.25-3.54) 
 
0.37  
1.00 (reference) 
6.08 (2.59-14.3) 
1.00 (reference) 
3.29 (1.80-5.98) 
 
0.19 
  Nu   Nu  
Tans easily 
Tan if work at it/unable to tan  
1.00 (reference) 
2.16 (0.65-7.21) 
1.00 (reference) 
2.22 (1.44-3.42) 
 
0.84  
1.00 (reference) 
8.58 (1.83-40.3) 
1.00 (reference) 
3.76 (2.25-6.29) 
 
0.33 
  1Odds ratios (OR) and 95% confidence (CI) intervals adjusted for age and gender 
  2p-value for interaction between genus specific HPV seroreactivity and sunlight related factor 
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CHAPTER 4: 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Non-melanoma skin cancer (NMSC), comprised of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC), is the most frequently occurring cancer among 
U.S. men and women.  Exposure to ultraviolet (UV) radiation is an established risk factor 
for NMSC, but despite the current knowledge about the harm of sunlight exposure and 
increased use of sunscreen, NMSC incidence rates continue to increase, emphasizing 
the critical need to better understand the role of sunscreen use in preventing NMSC and 
differences in sunlight exposure response relationships for BCC and SCC.  Furthermore, 
it’s important to identify additional risk factors for NMSC that may better characterize 
individuals at high risk and aid in the development of novel prevention strategies.  A 
case-control study was conducted to investigate sunscreen use and to identify 
differences in the exposure response relationship between measures of patterns and 
timing of sunlight exposure and BCC and SCC.  We also investigated the potential 
modifying effects of cutaneous HPV seroreactivity on the associations between sunlight 
exposure and NMSC. 
Unlike previously published studies, we investigated multiple measures of 
sunlight exposure in BCC and SCC simultaneously and observed similar patterns of 
sunlight exposure to be associated with BCC and SCC risk.  Specifically, history of 
blistering sunburn (a marker of intermittent sunlight exposure) and occupational sunlight 
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exposure (i.e. having a job in the sun for ≥3 months for >10 years) were both associated 
with BCC and SCC.  The major differences in patterns of sunlight exposure between 
BCC and SCC were observed for sunlight exposure in one’s thirties when adjusting for 
skin susceptibility factors.  Additionally, sunlight exposure in one’s twenties was 
associated with SCC, regardless of pattern of exposure; similar associations were not 
observed for BCC.  Measures of timing of sunlight exposure consistently demonstrated 
that childhood/adolescent sunlight exposure was statistically significantly more important 
for SCC than BCC.  Specifically, having ≥10 moles on one’s forearms and entire body (a 
marker of increased childhood sunlight exposure), younger age at blistering sunburn and 
tanning bed use were associated with SCC.  Among BCC cases, the only statistically 
significant association observed was for younger age at blistering sunburn.  However, 
despite differences in statistical significance in sun-related factors between BCC and 
SCC, case-only analyses demonstrated that the observed ORs were not significantly 
different in magnitude between BCC and SCC for measures of patterns and timing of 
sunlight exposure.  This additional information supports the observation that patterns of 
sunlight exposure are more similar than different between BCC and SCC.   
It has been hypothesized that intermittent patterns of sunlight exposure and 
exposure in childhood are important for BCC while continuous, lifelong sunlight exposure 
is import for SCC.  However, the current study did not support clear differences in the 
exposure response relationships between patterns or timing of sunlight exposure for 
BCC and SCC.  Understanding how sunlight exposure response differs for BCC and 
SCC is important for better educating the public in sunlight safe behaviors.  Simply 
advising a reduction in sunlight exposure will not help reduce the incidence of NMSC if 
changes in sunlight exposure patterns are related to skin cancer development.  For 
example, applying sunscreen while on vacation may decrease BCC risk associated with 
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intermittent sunlight exposure, but may not impact the risk of SCC, which may be more 
strongly related with continuous sunlight exposure.  Further studies are needed to 
highlight differences in the exposure-response relationship of patterns and timing of 
sunlight exposure with BCC and SCC.  Furthermore, standardized methods for 
measuring sunlight exposure should be established to enable comparisons across 
different study populations. 
Despite not observing clear differences in patterns and timing of sunlight 
exposure between BCC and SCC, measures of sunlight related factor were associated 
with BCC and SCC in our study population.  As mentioned above, incidence rates of 
BCC and SCC continue to rise each year in the U.S. despite the growing knowledge of 
the harm caused by UVR exposure and increasing use of sunscreen products and other 
sun safe behaviors.  Therefore, there is a need to identify potential co-factors in the 
relationship between UVR and NMSC, such as skin sensitivity to sunlight exposure and 
cutaneous HPV infection.   
If sunscreen use has the potential to protect against skin cancer development, 
we would expect to observe a reduced risk in BCC and SCC among individuals that 
frequently use sunscreen products when exposed to UV radiation.  We investigated the 
association between self-reported sunscreen use with sun protection factor (SPF) ≥15 
and NMSC stratified by skin sensitivity to 1 hour of sunlight exposure in the mid-day sun 
and tanning ability after repeated sunlight exposure (see Appendix 2).  The study had 
insufficient power to conduct stratified analyses and therefore it’s difficult to make 
inferences based on the observed results.  However, despite this limitation, evidence 
from the study (Appendix 2) suggests that skin reaction to sunlight exposure may modify 
the associations between sunscreen use and NMSC. 
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Previous studies have demonstrated that cutaneous HPV infection may be 
associated with NMSC, especially SCC.  It has also been hypothesized that UVR and 
cutaneous HPV may interact in a synergistic manner in NMSC development.  Within the 
same case-control study, potential modifying effects of cutaneous HPV seroreactivity on 
the associations between sunlight related skin cancer risk factors and BCC and SCC 
were investigated.  Specifically, interactions were tested between cutaneous sensitivity 
to sunlight exposure, tanning ability, history of blistering sunburn, and cumulative 
sunlight exposure and seroreactivity to cutaneous HPV types in genera alpha, beta, 
gamma, mu, and nu.   
As expected, the sunlight related skin cancer risk factors listed above were 
associated with an increased risk for both BCC and SCC in our study population.  NMSC 
cases were more likely to be seropositive for cutaneous HPV antibodies compared to 
controls and individuals with sun sensitive skin (i.e. tendency to burn) were more likely to 
be seropositive for HPV compared to those with a tendency to tan.  Additionally, 
cutaneous HPV seroreactivity modified the effects between sunlight related factors and 
NMSC.  Specifically, propensity to sunburn was more strongly associated with BCC 
among individuals that were seronegative for genus gamma HPV types.  Poor tanning 
ability was more strongly associated with both BCC and SCC among individuals 
seropositive for HPV types in genera alpha and beta. 
The proposed study has some limitations.  Case-control studies are often subject 
to recall bias because cases tend to think about their exposures more carefully as they 
might relate to their current cancer diagnosis.  Sample sizes for stratified analyses were 
limited, reducing poser to detect statistically significant interactions.  Despite the 
limitations, several strengths should also be noted.  The current study was the first case-
control study to formally evaluate measures of patterns and timing of sunlight exposure 
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in NMSC in a high risk U.S. population as well as present findings simultaneously for 
both skin cancer types, BCC and SCC.  This presentation allowed for direct comparisons 
of patterns and timing of sunlight by skin cancer type.  Additionally, the current study 
presents cutaneous HPV genus-specific associations outside of genus alpha and beta in 
a U.S. population.  It was also the first study to investigate interaction effects between 
genus-specific HPV seropositivity and multiple measures of sunlight exposure as they 
relate to both BCC and SCC in a U.S. population.  In addition, the measurement of 
antibodies to HPV was not subject to problems with recall bias.  The use of Dr. Pawlita’s 
assay to test for seropositivity to all identified cutaneous HPV types is a great strength of 
the proposed study.  Dr. Pawlita’s laboratory has been used in most of the 
seroepidemiologic studies of cutaneous HPV published to date(29, 34-37, 78), including 
the two studies published from the U.S. in New Hampshire(34, 72).  This will allow us to 
directly compare our results to those observed in New Hampshire where levels of UV 
radiation exposure are significantly lower compared to Florida.   
UV radiation exposure remains the most important environmental risk factor for 
NMSC despite the increased use of sunscreen products as well as increasing 
knowledge of the harms of sunlight exposure.  The annual incidence of NMSC continues 
to rise each year in the U.S., therefore creating a need to better understand the 
mechanisms of this complex relationship as well as to identify cofactors that may interact 
with UV radiation exposure to increase the risk of NMSC so novel prevention strategies 
can be developed.  Clear differences in measures of patterns and timing of sunlight 
exposure between BCC and SCC were not observed in our study population.  However, 
there is a need to assess multiple factors when studying sunlight related risk factors in 
skin cancer.  More qualitative research studies need to be conducted to better 
understand how constitutional factors, as well as cumulative ambient solar radiation, 
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recreational activities, clothing worn when exposed to UVR, and geographic residence 
all influence the frequency of sunscreen use and its potential protective effects in NMSC.  
Additionally, knowledge of how sunscreen use may relate to patterns and timing of 
sunlight exposure is important for educating the public on better sun safe behaviors.  We 
observed an interaction between poor tanning ability and genus-specific HPV 
seroreactivity.  However, the precise relationship between one’s skin reaction to sunlight 
exposure and cutaneous HPV infection as they related to NMSC development require 
further investigation.  Evidence in the published literature investigating the association 
between cutaneous HPV and NMSC is limited and more epidemiologic studies are 
needed to better understand the association between UV radiation exposure and 
cutaneous HPV infection as they relate to NMSC development.  A majority of the studies 
investigating the association between cutaneous HPV seropositivity and NMSC only 
included cutaneous HPV types from genus beta and their associations with SCC.  
Additional research studies are need to identify how differences in sunscreen use, 
sunlight exposure, and cutaneous HPV infections influence the development of BCC and 
SCC with the intent of better characterizing individuals at high risk.  This information is 
pertinent in developing novel prevention strategies to reduce the incidence and burden 
of NMSC.   
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1. BACKGROUND AND PUBLIC HEALTH SIGNIFICANCE 
1. a. Epidemiology of non-melanoma skin cancer 
Descriptive epidemiology of non-melanoma skin cancer 
Non-melanoma skin cancer (NMSC), comprised of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC), is the most common cancer in Caucasians, with 
more than one million new cases diagnosed annually in the United States alone(1).  The 
occurrence of BCC is four times more common than SCC, accounts for 75-80% of skin 
cancers, and rarely metastasizes to other organs(12, 79).  In white populations in the 
U.S., the annual incidence of BCC increases by more than 10% each year, and the 
estimated lifetime risk is 28-33%(12, 79). SCC accounts for 20% of skin cancers, and its 
incidence increases by approximately 3-10% per year.  SCC has the rare potential to 
spread to the lymph nodes and other organs leading to an increased risk of death 
among SCC patients compared to BCC patients(12, 80).  The lifetime risk of developing 
SCC among fair-skinned persons in the US is 7-11% (9-14% in men and 4-9% in 
women)(12).  Additionally, NMSC is more common among males compared to females 
with a ratio of 2 to 1 for BCC and 3 to 1 for SCC.  In 1994 it was estimated by Miller and 
Weinstock that NMSC accounts for 1300 to 2300 deaths per year, mostly from 
metastatic SCC(54).  While the mortality associated with NMSC is low(2), patients with 
multiple NMSC’s may experience substantial morbidity, and treatment costs for NMSC 
are high at the national level.  In 1995, treatment for NMSC and its precursors accounted 
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for $852 million in Medicare costs, equivalent to 90% of the costs associated with breast 
cancer treatment(55). Furthermore, a history of NMSC has been consistently associated 
with increased risk of subsequent primary cancers of other sites in studies from both the 
U.S. and Europe(3-11).   
Risk factors for non-melanoma skin cancer 
Identified risk factors for BCC and SCC include older age, male sex, light eye 
(blue, green, or hazel), hair (red or blonde), and skin (fair) color, and 
immunosuppression(12).  Organ transplant recipients have a 50 to 100 fold increased 
risk of NMSC compared to the general population(81, 82).  In organ transplant recipients 
SCC occurs more frequently than BCC (4:1) and has a higher incidence of metastasis 
compared to the general population(80).   In addition, long-term use of systematic 
glucocorticoids, a type of immunosuppressive therapy, has been shown to increase the 
risk of developing both SCC and BCC(83).  Rare genetic disorders are also associated 
with NMSC, including Epidermodysplasia Verruciformis (EV), which is characterized by 
multiple flat warts and macular skin lesions that often progress to SCC(84).  Lifestyle 
factors such as smoking have also been proposed as risk factors for NMSC, mainly 
SCC, although findings are inconsistent across studies(13-28). 
Ultraviolet radiation (UVR) exposure has been implicated in the etiology of skin 
cancer and is considered the most important environmental risk for both BCC and SCC 
development.  However, the precise relationship between UVR and the risk of NMSC is 
complex, and the relationship may differ by skin cancer type.  Evidence from previous 
studies suggest that intermittent sunlight exposure is important for the pathogenesis of 
BCC, whereas cumulative sunlight exposure is important for SCC, but the exact 
relationship between the amount, patterns and timing of UVR exposure and risk of BCC 
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and SCC still remain unclear.  In addition to sunlight exposure, epidemiologic studies 
have demonstrated that cutaneous human papillomavirus (HPV) infection may be a risk 
factor for developing NMSC.  However, the pathway by which cutaneous HPV is 
associated with NMSC remains unclear.  It is hypothesized that UVR exposure may 
interact synergistically with cutaneous HPV in NMSC development.   
1. b. Ultraviolet radiation exposure in non-melanoma skin cancer 
 Ultraviolet-A (UVA) and ultraviolet-B (UVB) radiation are responsible for causing 
DNA damage to the skin, leading to all types of skin cancer.  When using epidemiologic 
approaches to study the relationships between ultraviolet radiation (UVR) and NMSC, it 
is difficult to separate the effects of UVA versus UVB exposure.  Therefore, 
epidemiologic studies tend to identify UVR as “sunlight” exposure as a whole.  Several 
lines of evidence from epidemiologic studies support the association between sunlight 
exposure and NMSC.  This evidence includes higher NMSC incidence among: 1) 
persons living in geographic areas with higher ambient solar radiation; 2) persons with 
sun sensitive skin (fair-skinned); 3) frequently sun exposed anatomical sites; 4) persons 
experiencing frequent sun exposure and 5) persons with other sun related skin 
conditions. In addition, incidence rates are lower among persons who practice sun safe 
behaviors (e.g. sunscreen use).(85)  However, despite epidemiologic and molecular 
evidence supporting the causal relationship between sunlight exposure and NMSC, the 
exact biological mechanism underlying the association remains unclear.  The way in 
which the amount, pattern, and timing of sunlight exposure effects skin cancer 
development still remains to be answered. 
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1. c. Sunscreen use as prevention for basal cell and squamous cell carcinoma 
As mentioned previously, a majority of epidemiologic studies measure exposure 
to “sunlight” (UVR as a whole) and are unable to distinguish different components of the 
UV spectrum responsible for the induction and promotion of BCC or SCC.  Sunscreens 
were originally formulated to protect against UV-induced sunburns, thought to be caused 
mostly by UVB radiation.  Laboratory studies in rodents revealed that sunscreens had 
the potential to reduce UV-induced skin cancer, such as SCC(86).  Animal models have 
not supported similar findings for BCC or melanoma.  However, despite the lack of 
evidence that sunscreens can protect against BCC or melanoma occurrence, sunscreen 
products are advocated for the prevention of all types of skin cancers.  Currently 
available sunscreens provide broad spectrum coverage (UVA and UVB).  However, 
observational studies have found sunscreen use to be associated with increased risk for 
BCC and an increased incidence of melanocytic nevi among children and adolescents.  
Randomized controlled trials demonstrated that sunscreens had the ability to reduce the 
occurrence of solar keratoses (precursors for SCC) and of SCC, however, no effect was 
observed for BCC(87-89).   
Thompson et al. conducted a trial among residents from Victoria, Australia of at 
least 40 years of age with a history of sun-induced skin damage(87).  Subjects either 
applied a sunscreen cream or a base cream (placebo) that did not contain any active 
ingredients of the sunscreen.  Results from the trial showed the ability of daily sunscreen 
use to reduce the rate of new solar keratosis by 40% (RR=0.62; 95% CI=0.54-0.71), 
compared to using the placebo.  Additionally, the average remission of solar keratosis 
was 28% and 20% for the sunscreen group and base cream group, respectively, and the 
estimated likelihood of remission of lesions present at baseline was greater in the 
sunscreen group compared to the placebo group (OR=1.53; 95% CI=1.29-1.80).   
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The Nambour Skin Cancer Prevention Trial began in 1992 among a random 
selection of residents living in Nambour, a township of Queensland, Australia, who were 
ages 20 - 69 in 1986.  The trial aimed to test the effectiveness of regular sunscreen use 
on the head, neck, hands, and forearms to prevent against SCC and BCC occurrence.  
Among participants being followed between 1992 and 1996, a reduction in SCC 
incidence was observed for daily sunscreen use, compared to no sunscreen use, among 
individual participants (RR=0.88; 95% CI=0.50-1.56), as well as for the overall number of 
SCC tumors (RR=0.61; 95% CI=0.46-1.81) that developed during the four year study 
follow-up period(88).  However, these differences were not statistically significant.  No 
reduction of BCC was associated with daily sunscreen use among this study population.  
Van der Pols and colleagues continued to follow participants from the Nambour Trial for 
eight years after its completion to test the potential latent effect of sunscreen use to 
prevent BCC and SCC(89).  A reduced rate of SCC occurrence was observed among 
daily sunscreen users (RR=0.62; 95% CI=0.43-0.98), compared to no daily sunscreen 
use, but a similar reduction in BCC incidence was not observed (RR=1.02; 95% 
CI=0.75-1.37).  Additionally, daily sunscreen use was associated with the development 
of fewer skin cancer tumors compared to the number of tumors for no daily sunscreen 
use.  However, this association was stronger for SCC (RR=0.62; 95% CI=0.38-0.99) 
than BCC (RR=0.89; 95% CI=0.64-1.25).  The Nambour Trial was conducted in 
Queensland, Australia, in a population with both high ambient solar radiation year round 
and the highest incidence of skin cancer worldwide. 
In contrast to evidence provided by randomized controlled trials, observational 
studies have not demonstrated protective effects of sunscreen use against either type of 
NMSC.  However, a majority of the published studies focused on the effects for BCC 
only.  Two cohort studies observed increased risk of BCC and SCC associated with 
64 
 
sunscreen use.  Results from a cohort study of female registered nurses 30 to 55 years 
of age living in the United States concluded that sunscreen use while outdoors was 
related to an increased risk of BCC(19).  More specifically, a statistically significant 
decreased risk was observed for BCC among participants that reported not using 
sunscreen at baseline (RR=0.70; 95% CI=0.60-0.82) compared to usually using 
sunscreen when outdoor in the summer for at least 8 hours per week.  Among actinically 
damaged individuals, ages 21 - 85 years, living in Arizona, sunscreen use was 
associated with increased risk for BCC and SCC, though none of the associations were 
statistically significant(68).  Compared to never use at baseline, using sunscreen more 
than half of the time over the five year follow-up period was associated with RRs of 1.14 
(95% CI=0.67-1.95) and 1.23 (95% CI=0.66-2.29) for BCC and SCC, respectively.  
Participants reporting always using sunscreen had RRs of 1.55 (95% CI=0.94-2.54) and 
1.42 (0.79-2.55) for BCC and SCC, respectively, compared to not using sunscreen 
during study follow-up.    
Results from case-control studies of the associations between sunscreen use 
and NMSC have also been inconclusive.  A study conducted among U.S. women from 
Nashville, Tennessee between 20 and 40 years of age showed no association between 
sunscreen use and BCC (p=0.563)(14).  A dermatological hospital based case-control 
study from Italy showed a 40% reduced likelihood of BCC among those using sunscreen 
always or often versus never (OR=0.6; 95% CI=0.3-1.4), but this association was not 
statistically significant(16).  In contrast, use of sunscreen sometimes or rarely, compared 
to never, showed an increased likelihood for BCC (OR=1.2; 95% CI=0.6-2.7), but once 
again this association was not statistically significant.  Among participants from the 
Geraldton Skin Cancer Prevention Survey, the use of sunscreen (on the site of BCC 
diagnosis) with a SPF of at least 10 half of the time or more compared to never or less 
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than half of the time when sun exposed was associated with an increased risk of BCC:  
the ORs for 1 - 9 and ≥10 years of sunscreen use half of the time or more were 1.92 
(95% CI=1.17-3.13) and 1.25 (95% CI=0.82-1.90), respectively, compared to using 
sunscreen never or less than half of the time when sun exposed(52).  Additionally, using 
sunscreen with a minimum 10 SPF half of the time or more compared to never or less 
than half of the time 1 to 9 years prior to diagnosis was associated with an almost 80% 
increased likelihood for BCC (OR=1.77; 95% CI=1.09-2.87).  Among the same study 
population from Western Australia, English and colleagues observed no statistically 
significant associations for any use of SPF 10 compared to no use and SCC for any age 
interval: 8-14 (OR=0.61; 95% CI=0.08-4.7), 15-19 (OR=1.9; 95% CI=0.82-4.4), and 20-
24 (OR=0.99; 95% CI=0.44-2.2) years(53).   
 The difficulty in demonstrating a protective effect of sunscreen use on BCC and 
SCC from observational studies may be explained by prolonged sun exposure with 
sunscreen use, and therefore an increase in UV-induced skin damage and/or sunburn 
occurrence, when sunscreens are used.  Additionally, the increased risk of BCC or SCC 
associated with using protective measures in the recent past may be due to high risk 
individuals adopting protective behaviors.  Therefore, sunscreen use for prevention 
against skin cancer remains a controversial topic as NMSC rates continue to rise despite 
increased sales and use of sunscreen products.   
1. d. Patterns and Timing of sun exposure in basal cell and squamous cell 
carcinoma 
Beginning in the late 1950s, researchers began to conduct case-control studies 
to identify risk factors for NMSC, including total (cumulative) outdoor sun exposure hours 
and sun exposure on working and non-working days(19, 47-49).  These studies 
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demonstrated that BCC and SCC have different exposure-response relationships with 
sun exposure.  However, few epidemiologic studies have formally evaluated the 
relationship between patterns and timing of sun exposure in BCC and SCC.  Patterns of 
exposure refer to whether sun exposure was experienced continuously (chronic 
exposure) or sporadically (intermittent exposure).  For example, persons working 
outdoors, such as farmers, or living in geographic regions with a high annual UV index, 
such as Florida, are classified as having had chronic sun exposure.  Alternatively, 
intermittent sun exposure refers to persons working indoors and experiencing most of 
their sun exposure on the weekends or persons living in northern latitudes with a low UV 
index being exposed to high doses of sun exposure while on vacation to regions with 
high UV index.  Continuous or chronic sun exposure has been observed to be 
associated with the development of SCC, whereas intermittent sun exposure has been 
observed to be associated with BCC.  Timing of sun exposure refers to what period in 
life the majority of a person’s sun exposure was received, in early childhood, adulthood 
or both.  Others have speculated that a high level of sunlight exposure in childhood is 
more strongly associated with SCC while exposure in adulthood is more strongly 
associated with BCC.   
1. e. Patterns of sun exposure in basal cell and squamous cell carcinoma 
In 1990, Vitasa and colleagues published results from a case-control study 
investigating the relationship between UVB radiation and SCC, BCC, and actinic 
keratosis (AK) among white, male watermen of at least 30 years of age residing in the 
Eastern Shore or Maryland(49).  It was observed that subjects with SCC and AK 
experienced higher annual UVB radiation exposure (11% and 8%, respectively) 
compared to their age matched controls, while BCC cases had about 8% less UVB 
radiation exposure compared to their age matched controls between 15 and 60 years of 
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age.  Participants whose cumulative UVB radiation exposure exceeded the third quartile 
were more than two times likely to have SCC (OR=2.53, 95% CI=1.18-5.40) compared 
to those with lower UVB exposure.  However, no statistically significant associations 
were observed for BCC (OR=1.11, 95% CI=0.50-2.44) or AK (OR=1.48, 95% CI=0.99-
2.22). 
One of the first studies to formally evaluate the association between patterns and 
timing of sun exposure and NMSC was a population-based nested case-control study by 
Kricker and colleagues(52), among residents of Western Australian between 40 and 64 
years of age from the Geraldton Skin Cancer Prevention Survey(90).  The nested-case 
control study aimed to investigate the association between intermittent sun exposure 
and BCC development(52).  The primary measure of intermittent sun exposure was 
estimated by the amount of sun exposure experienced on “non-working” days relative to 
the amount experienced during the rest of the week.  “Sun exposure on non-working 
days was considered to be potentially intermittent only if subjects reported 2 days or less 
per week of non-working time”(52).  Additionally, markers of intermittent sun exposure 
included participation in outdoor recreational activities, sun exposure received on 
holidays, and history of painful and blistering sunburns.  An odds ratio of 3.86 
(95%CI=1.93 – 7.75) was observed for 100% intermittency of sun exposure and an odds 
ratio of 1.82 (95% CI=1.01-3.28) was observed for 59-99% intermittency of sun exposure 
compared to 0-40% intermittency of sun exposure in late teenage (15-19 years) for risk 
of BCC.  BCC was also positively associated with increasing intermittency of sun 
exposure among participants 15-19 years old (p for trend = 0.001).  Similar patterns of 
intermittent sun exposure were not observed for participants in the 20-24 or 25-39 year 
old groups.  Kricker et al. also assessed intermittent sun exposure in the ten years prior 
to diagnosis and an increased risk for BCC was positively associated with 25-49% 
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(OR=1.75; 95% CI=1.15-2.66) and 50-99% (OR=2.10; 95% CI=1.25-3.54) intermittency.  
An odds ratio of 1.22 was observed for 100% intermittency in the 10 years prior to BCC 
diagnosis but was not statistically significant.  Increasing hours of sun exposure between 
9am and 5pm on the site of skin cancer diagnosis during holiday (vacation) was 
associated with increasing risk of BCC, especially at 15 – 19 years of age (p for trend = 
0.01).  No associations between outdoor recreational activities and risk of BCC were 
observed among this study population.   
In 1998, the same research group conducted a nested case-control study of 
patterns and timing of sun exposure with risk for SCC(53), using the same study 
population based on the Geradton Skin Cancer Prevention Survey(90), of residents of 
Western Australia ages 40 - 64 years.  Similar to the investigations for BCC, the 
research group aimed to quantify the relationship between the risk of SCC by the 
amount and pattern of sun exposure(53).  The amount of sun exposure was examined 
by estimating the total lifetime ambient solar irradiance experienced.  The amount was 
calculated by measuring the average daily global UV radiance and the average daily 
hours of bright sunlight over the participant’s lifetime residential history.  The highest 
odds ratio observed for accumulated (lifetime) hours of bright sunshine and SCC was 
5.2 (95% CI=1.6-16) for the second highest category of exposure (150,700 to 170,499 
hours), whereas a lower odds ratio of 3.5 (95% CI=0.97-12) was observed for the 
highest category of exposure (170, 500 plus hours).  Additionally, a lower average daily 
global UV radiance was significantly associated with a 2 fold increased risk for SCC 
(OR=1.9, 95% CI=1.1-3.4), however, lower insignificant risks were observed for higher 
levels of daily UV radiance.   
English and colleagues(53) also assessed the effect of patterns (continuous vs. 
intermittent) of sunlight and SCC by three methods: first, by analyzing sunlight exposure 
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on working and non-working days; second, by calculating sunlight exposure on non-
working days for the site of SCC diagnosis; and third by examining history of sunburn, 
sunbathing, vacations and outdoor leisure activities.  To assess an intermittent pattern of 
sun exposure the investigators measured the amount of sun exposure to the site of SCC 
diagnosis on non-working days across age intervals from 15 to 39 years of age.  For 
anatomic sites usually exposed to sunlight on working days, no statistically significant 
observations with SCC were observed for any category of sun exposure hours, but the 
most elevated odds ratio was observed for the intermediate (OR=1.7, 95% CI=0.81-3.8), 
not the highest (OR=1.3, 95% CI=0.58-2.8) category of sun exposure.  For sun exposure 
on a usually exposed anatomic site during non-working days, a decreasing trend in the 
magnitude of the odds ratios for SCC was observed from the lowest (OR=2.0, 95% 
CI=0.89-4.4) to highest (OR=1.3, 95% CI=0.57-2.9) levels of sun exposure.  A 
continuous effect of sun exposure on working days and SCC was investigated by 
examining exposure on working days across specific age intervals.  The strongest 
association between the amount of sun exposure on working days and SCC was 
observed for individuals 15-19 years of age (OR=2.2 for 22 hours per week of sun 
exposure).  The authors report that the maximum odds ratios for hours of sun exposure 
on working days and SCC were lower for the other age groups but the corresponding 
estimates were not reported.  With the exception of frequent gardening (OR=1.8; 95% 
CI=1.0-3.2) and field sports (OR=1.7; 95% CI=1.1-2.8), no associations were observed 
between outdoor recreational activities and SCC.  Additionally, no associations were 
observed between lifetime frequency of sunbathing or number of hours of exposure to 
the site of SCC on holidays (vacations), when site of diagnosis was sun exposed. 
 From 1989 to 1993, Rosso and colleagues undertook a case-control study to 
investigate the potential risk factors, including hours of sun exposure during different 
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activities and time periods, for BCC and SCC among south European populations 
ranging in age from 20 to 70 years old(51).  Investigators calculated lifetime hours of sun 
exposure based upon duration and type of activity, as well as period of life (childhood, 
adolescence, adulthood, retirement) and sun exposed body parts.  Sun irradiation was 
considered by taking into account the season individuals participated in the activities (i.e. 
outdoor work, sports and recreational activities, and holidays).  Associations of BCC and 
SCC with lifetime sun exposure were estimated for outdoor work, outdoor sports and 
holidays.  With less than 7200 hours of lifetime sun exposure as the reference group, no 
statistically significant associations were observed between any quartile of lifetime sun 
exposure during outdoor work and BCC or SCC.  However, statistically significant linear 
trends with SCC for increasing lifetime sun exposure hours were observed for all 
participants (including unexposed, i.e. <7200 sun exposed hours) (p=0.029) and among 
exposed participants only (i.e. >7200 sun exposed hours) (p=0.008).  Similar trends 
were not observed for BCC. 
Similar to results observed among participants from the Geraldton Skin Cancer 
Prevention Survey(52, 53), sun exposure during holidays showed statistically significant 
associations with BCC, but not with SCC.  Specifically, sun exposure hours in the 
second (280-1323 hours) and fourth (>3398 hours) quartiles were associated with ORs 
of 1.26 (CI=1.01-1.56) and 1.47 (CI=1.18-1.83), respectively, for BCC compared to 
never experiencing sun exposure on a holiday.  Additionally, statistically significant linear 
trends for increasing sun exposure hours on a holiday and BCC was also observed 
(p=0.036).  Though sun exposure during holidays was not associated with SCC across 
any of the quartiles, a linear trend (with borderline significance) for increasing sun 
exposure was observed for SCC (p=0.047).  The association between BCC and sun 
exposure during holidays was reinforced by restricting analyses to include beach 
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holidays only.  Similar to previous observations, statistically significant elevated odds 
ratios between BCC and lifetime sun exposed hours were observed for the second 
(OR=1.25, 95% CI=1.00-1.54; for 184 to 831 hours) and fourth (OR=1.58, 95% CI=1.27-
1.96; for ≥2464 hours) quartiles of sun exposure hours.  In contrast, lifetime sun 
exposure in the second (184 to 831 hours) and third (832 to 2464 hours) quartiles on a 
beach holiday appeared to be protective for SCC, with ORs of 0.59 (95% CI=0.36-0.96) 
and 0.47 (95% CI=0.27-0.80), respectively.  However, a linear trend for increasing 
number of sun exposed hours was associated with BCC (p<.001), but not with SCC 
(0.128), for holidays at a beach.  Associations between lifetime sun exposure during 
outdoor sports and BCC and SCC varied by activity.  Taking into account all outdoor 
sport activities, no statistically significant associations or trends were observed for either 
BCC or SCC.  However, when stratified by type of outdoor activity, the number of hours 
spent outdoors participating in water sports (for the second, third, and fourth quartiles of 
exposure) was associated with BCC (p for trend = <0.001), but not SCC (p for trend = 
0.567), while sun exposure during sports in the mountains or air were not associated 
with either BCC or SCC.           
1. f. Sunburn and basal cell and squamous cell carcinoma 
 Epidemiologic studies investigating risk factors for NMSC have reported 
associations with history/frequency of blistering and/or painful sunburns with mixed 
results.  In the published literature, history of blistering sunburn is regarded as a marker 
of intermittent sun exposure and consequently is hypothesized to be associated with 
BCC.  However, evidence from the literature supports a stronger relationship between a 
history of blistering sunburn with SCC than BCC.  For example, two case-control studies 
from the Geraldton Skin Cancer Prevention survey of Western Australian residents 
investigated independent associations of blistering sunburns and painful sunburns with 
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BCC and SCC(52, 53).  Kricker and colleagues(52) observed that 3 to 10 painful 
sunburns at the site of diagnosis was associated with an almost 2 fold increased 
likelihood of BCC (OR=1.75; 95% CI=1.08-2.85) compared to those with no history of 
sunburn.  Smaller effects were observed for the frequency of blistering sunburn at the 
site of BCC diagnosis and did not reach statistical significance.  Specifically, the OR for 
1 to 2 blistering burns was 1.6 (95% CI=0.92-2.79) and 3 or more blistering sunburns 
was 1.24 (95% CI=0.69-2.24) compared to never experiencing a sunburn(52).  English 
and colleagues(53) observed that a history of blistering sunburn to the site of SCC 
diagnosis was more strongly associated with SCC compared to a history of painful 
sunburns only.  For example, an odds ratio of 2.1 was observed for either 1 to 2 (95% 
CI=1.0-4.6) or 3 + (95% CI=1.0-4.3) blistering burns compared to none, while a history 
of only a painful sunburn compared to none showed no association with SCC (OR=1.1; 
95% CI=0.67-1.8)(53).  A case-control study of young women from the U.S.(14) reported 
no association between the average number of blistering sunburns and BCC compared 
to women without a similar history (p=0.06).  A nested case-control study of participants 
from the Nurses Health Study of registered female nurses from the U.S.(67) observed 
statistically significant associations between increasing numbers of severe sunburns that 
blistered and SCC (p=0.04) but similar associations were not observed for BCC 
(p=0.15).  Among actinically damaged adults from the U.S.(68) participating in a 
chemoprevention trial, having a history of severe sunburns that blistered compared to no 
sunburn at baseline was not significantly associated with BCC (RR=1.26; 95% CI=0.90-
1.77) or SCC (RR=0.86; 95% CI=0.58-1.27). 
Four additional studies in the published literature investigated the associations 
between severe and/or painful sunburns with BCC and SCC.  Results from a case-
control study conducted in Saskatchewan, Canada(18), showed that having a history of 
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severe sunburns was significantly associated with SCC compared to individuals that 
never experienced a severe sunburn (p=0.001).  Among participants from the Helios I 
study(91), a multi-center case-control study of southern Europe, a dose-response 
association was observed with BCC for increasing number of lifetime sunburns 
compared to never experiencing a sunburn (p=0.03).  However, similar associations 
were not observed with SCC (p=0.53).  Similarly, a prospective cohort study of men 
health professionals from the U.S.(27) observed statistically significant increasing risks 
for BCC with an increasing number of sunburns compared to no sunburns over a lifetime 
(p=<.0001).  A prospective cohort study of U.S. women(19) also demonstrated 
increasing risk for BCC with an increasing number of lifetime sunburns compared to no 
sunburns (p=<.001). 
1. g. Tanning bed use and basal cell and squamous cell carcinoma 
 Six studies from the published literature report on the association between 
tanning bed use and BCC and SCC.  Four of the six case-control studies(14, 16, 67, 92) 
reported no association between ever versus never using a sunlamp or tanning bed and 
BCC or SCC, including studies from Canada, the U.S. and Italy.  However, Aubry and 
colleagues(13) conducted a hospital based case-control study of SCC in Montreal, 
Canada and observed a statistically significant association between ever versus never 
use of a sunlamp and SCC (OR=13.42; 95% CI=1.38-130.48).  A population based 
study from New Hampshire (NH)(93) observed statistically significant associations 
between ever versus never using a tanning device for both BCC (OR=1.5; 95% CI=1.1-
2.1) and SCC (OR=2.5; 95% CI=1.7-3.8).  Additionally, compared to never users, age at 
first tanning bed use (less than 20 years old) and time since last tanning bed use 
(greater than 20 years) was significantly associated with BCC and SCC among the 
participants from the NH study.     
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1. h. Timing of sun exposure in basal cell and squamous cell carcinoma 
 As mentioned previously, increasing levels of intermittent sun exposure and 
increasing hours of sun exposure during holidays (vacation) in late teenage years (15 to 
19) was associated with BCC among participants from the Geraldton Skin Cancer 
Prevention Survey in Western Australia(52).  Among the same study population, 
statistically significant associations were observed between total site specific sun 
exposure and SCC for age intervals 8 to 14 (OR=5.1), 15 to 19 (OR=3.8), and 20 to 24 
(OR=2.4) years(53).  For age intervals 25 to 34 and 35 to 39 years, no statistically 
significant associations were observed between total sun exposure and SCC.   
Several epidemiologic studies in the published literature investigated the 
associations between age (timing) of sunburn and risk for BCC and SCC.  Results from 
the Leiden Skin Cancer Study(94), a case-control study from Sweden, demonstrated 
that compared to no history of painful sunburns, experiencing painful sunburn and any 
age prior to 13 years of age was significantly associated with BCC.  However, for SCC, 
the only significant association observed was among participants reporting painful 
sunburns between 6 and 12 years of age.  A hospital based case-control study from 
Italy(16) did not observe statistically significant associations between history of sunburn 
before or after 20 years of age, compared to no history of sunburn, and BCC.  However, 
the mean number of weeks per year spent at the beach for summer holidays was 
significantly associated with BCC.  A dose-response relationship was observed for 
spending 3 to 4 (OR=1.8; 95% CI=0.8-4.4), 5 to 8 (OR=3.7; 1.5-9.0) or more than 8 
(OR=4.5; 95% CI=1.9-10.5) weeks, compared to 0 to 2 weeks per year (p for trend = 
0.01) at the beach for summer holidays before the age of 20 years.  The number of 
weeks per year spent at the beach after the age of 20 years was not significantly 
associated with BCC.  A case-control study from Spain of SCC of the lip in men(24) 
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observed a significant protective effect for experiencing first sunburn after 15 years of 
age (OR=0.1; 95% CI=0.003-0.6) compared to no history of sunburns.  An OR of 14.6 
was observed for lip SCC among males experiencing sunburn prior to 15 years of age; 
however, this association was not statistically significant.  Results from the Helios I 
study(91), a multi-center case-control study of southern Europe, demonstrated a 
statistically significant positive association between age at first sunburn and BCC, but 
not SCC.  Individuals experiencing their first sunburn younger than 15 years of age were 
more likely to have BCC compared to individuals that reported experiencing their first 
sunburn after 15 years of age or never at all (OR=1.68, CI=1.17-2.39).  Results from the 
Helios II study(51) demonstrated that the amount of sun exposure experienced in 
childhood during a holiday at the beach was associated with BCC, but not SCC.  The 
highest quartile of lifetime sun exposed hours (>2079 hours) during a beach holiday was 
associated with an OR of 1.43 (CI=1.09-1.89) compared to individuals never 
experiencing beach holiday.  No statistically significant observations were observed for 
SCC across any quartile of sun exposure hours.  Additionally, a dose-response 
relationship for increasing hours of sun exposure during childhood while on holiday at 
the beach was associated with BCC (p=0.005) but not with SCC (p=0.782). 
1. i. Acquired melanocytic nevi 
 Many epidemiologic studies have investigated the association between sun 
exposure in early childhood and nevus development.  Prospective studies in the 
published literature provide evidence that increasing sun exposure in early years of life is 
associated with melanocytic nevus development.  Since most nevi develop by the age of 
10, their presence in adulthood may be considered an indicator of high UV exposure in 
childhood. 
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 The SONIC study is an ongoing four year follow-up study of the natural history of 
nevi development among public and parochial school 5th graders (10 to 11 year olds) 
from Framingham, Massachusetts.  Oliveria and colleagues(64) reported baseline 
findings after 1 year of follow-up and observed a slight increased risk for nevi 
development for spending 5 to 6 hours outdoors between 10am and 4pm (RR=1.13; 
95% CI=1.00-1.28), compared to <1 to 2 hours (baseline), on a typical summer day.  No 
differences in nevi development were observed between participants spending 3 to 4 
hours outdoors (RR=0.93; 95% CI=0.83-1.04) compared to baseline. 
Pettijohn et al(65) investigated the relationship between waterside vacations and 
nevus count among lifetime residents of Colorado at age 7.  Results showed that with 
each additional waterside vacation taken one or more years prior to the skin exam 
received at age 7, the total number of nevi increased by 5% (p=0.01).  The investigators 
also measured the total UV dose received on waterside vacations as well as the duration 
of waterside vacations but these factors were not significantly related to the presence of 
nevi among this young population.  Additionally, non-waterside vacations were not 
significantly associated with nevus count.  
 In 2008, Harrison et al(63) published results looking at the association between 
sun exposure and incidence of melanocytic nevi among children 1 to 6 years of age and 
lifetime residents of Townsville, Australia.  After one year of follow-up, a positive dose 
response relationship was observed between the daily average number of sun exposure 
hours and the median incidence rate of nevi development (p=0.012).  The median 
incidence rate for less than one hour per day of sun exposure was 8.3 and increased 
steadily up to 4 or more hours of sun exposure per day with a median incidence rate of 
13.0 for melanocytic nevi development per one year of follow-up.  Additionally, the 
median incidence rate of melanocytic nevi development also increased with increasing 
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doses of UVR exposure needed to cause a sunburn while spending time outdoors during 
the one year of follow-up (p=0.034).      
 A longitudinal study conducted among German children 2 to 7 years of age from 
public nursery schools(60) observed a high incidence of total body nevus counts 
associated with increasing hours per day of sun exposure during holidays (intermittent, 
high sun exposure) (Regression coefficient=0.040; 95% CI=0.022-0.059) as well as with 
increasing hours per day of sun exposure during activities at home (chronic, moderate 
sun exposure) (Regression coefficient=0.043; 95% CI=0.012-0.075).  Thus, cumulative 
sun exposure appears to be an important risk factor for nevi development in this German 
study population.     
 Among school children from Brisbane, Australia (12 and 13 years old at 
enrollment) followed for five years(61), spending all of time in the midday sun during 
lunchtime was associated with a means ratio for whole body nevi counts of 1.62 (95% 
CI=1.15-2.29) compared to children that spent very little time in the sun during their 
lunch period.  Means ratios for spending most of the time and some of the time in the 
midday sun during lunchtime were 1.15 and 1.53, respectively, but failed to achieve 
statistical significance.  Additionally, spending more than 4 weeks at the beach per year 
during childhood was associated with a 59% higher whole body nevi count (Ratio of 
means=1.59; 95% CI=1.20-2.10) compared to children spending less than 1 week at the 
beach per year.   
 A population based study conducted in Hamburg, Germany of 5 to 6 year old 
primary school children(62) demonstrated that the number melanocytic nevi was 
associated with the number of holidays (vacations) in Southern Europe, a time when 
children would experience intermittent exposure with higher doses of UV exposure 
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compared to the daily sun exposure in Hamburg.  The mean numbers of melanocytic 
nevi were 14.2 (95% CI=13.7-14.7) and 12.8 (95% CI=12.5-13.2) for ≥2 and 1 holiday, 
respectively, in Southern Europe, compared to a mean number of melanocytic nevi of 
10.9 (95% CI=10.7-11.2) for no holidays in Southern Europe.   
1. j. Cutaneous human papillomavirus in non-melanoma skin cancer 
As mentioned previously, the number of NMSC cases increases each year in the 
United States alone.  Current prevention strategies, such as limiting the number of hours 
of sunlight exposure per day or applying sunscreen more frequently has not been 
effective in reducing the annual incidence of NMSC for either BCC or SCC.  Therefore, 
there is a need to identify potential co-factors that may interact with UV radiation to 
increase the risk of NMSC.  Epidemiologic studies have demonstrated a potential role for 
cutaneous HPV infections in NMSC development, so that novel prevention strategies 
may be developed.  Furthermore, it has been hypothesized that cutaneous HPV may 
interact synergistically with UV radiation exposure in NMSC development. 
Human papillomaviruses belong to a large family of more than 100 genotypes, 
with genus alpha comprising types that infect predominantly mucosal epithelia (including 
“high-risk” types associated with cervical cancer and “low-risk” types inducing benign 
mucosal lesions), and types that infect cutaneous epithelia(50).  HPV types that infect 
cutaneous epithelia have also been identified from genera beta, gamma, mu, and 
nu(50).   
Cutaneous HPV types in genus beta were identified from patients with  
Epidermodysplasia Verruciformis, a skin condition characterized by flat warts and 
macular skin lesions, which are suspected to be associated with SCC in these patients.  
The E6 and E7 oncoproteins encoded for by genus beta type HPV38 can interfere with 
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the tumor suppressor activities of both p53(95) and pRb(96) and immortalize 
keratinocytes through impairment of the telomerase system(97).  HPV38 E6 and E7 
have also displayed transforming properties in vivo(41).  Keratinocytes expressing the 
E7 oncoprotein encoded for by HPV8, another genus beta type, acquire the ability to 
penetrate basement membranes(39) and overexpress matrix metalloproteinases that 
may play a role in HPV8-associated carcinogenesis(39, 98), and the development of 
cutaneous NMSC has been documented in HPV8-transgenic mice(99, 100).  In addition, 
the E6 proteins of cutaneous HPV types have been shown to inhibit UV-radiation-
induced apoptosis(45), supporting a role for cutaneous HPV as a cofactor in skin 
carcinogenesis. Seventy-five percent of NMSC’s occurring in organ transplant recipients 
contain cutaneous HPV DNA(101), and estimates of HPV DNA prevalence in NMSC 
tissues from immunocompetent individuals range from 20-48%(32, 33, 101-103).  
Presence of antibodies against one or more of the genus beta HPV types has 
been associated with SCC in several epidemiologic studies (see Appendix Table E).  In 
an Australian case-control study, having antibodies to any of the genus beta HPV types 
tested was associated with a statistically significant four-fold increased risk of SCC 
(OR=3.9, 95% CI=1.4–10.7)(73).  The single published study from the U.S. was 
conducted in New Hampshire and reported a 50% increased risk of SCC among 
individuals seropositive for any of 16 genus beta HPV types tested, with those who had 
antibodies to more than one HPV type being at greater risk of SCC (OR=1.8, 95% CI = 
1.3-2.7) than those with antibodies to only one type (OR=1.5, 95% CI=1.0-2.1)(34).  An 
SCC risk of similar magnitude was also observed in association with seropositivity to one 
or more cutaneous HPV types in a Dutch population (OR=1.4, 95% CI=0.8-2.5)(30), 
although no association was observed in a Swedish population (OR=1.13, 95% CI=0.61-
2.12)(71) or a British population(29) for one beta HPV type (OR=0.5, 95% CI=0.1-1.7) or 
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2 or more beta HPV types (OR=1.0, 95% CI=0.4-2.5) compared to not being 
seropositive to any beta HPV types. 
Results from epidemiologic studies of cutaneous HPV and BCC are less 
consistent (see Appendix Table E). Among genus beta HPV types tested in the Dutch 
population, seropositivity to any of the types was not significantly associated with BCC 
(OR=1.3, 95% CI=0.8-2.1), although statistically significant increased risks of BCC were 
associated with antibodies to HPV 8 (OR=14.7, 95% CI=1.4-154) and HPV 20 (OR=3.5, 
95% CI=1.1-11.6)(30).   Neither of the studies from New Hampshire(34) or Sweden(71) 
observed increased risks of BCC associated with cutaneous HPV antibodies.  The other 
studies that investigated SCC did not include BCC, and there have been no studies of 
cutaneous HPV and BCC only.   
The published literature focuses on the associations between NMSC and 
cutaneous HPV types from genus beta.  However, a few more recent studies have 
presented results for cutaneous HPV types outside of genus beta(29, 34, 71).  No 
statistically significant associations between BCC and SCC with seropositivity to 
cutaneous HPV types in genus alpha were observed in studies among residents of New 
Hampshire(34), and Sweden(71).  Casabonne et al(29) also presented results for the 
associations between SCC and cutaneous HPV seropositivity for types from genuses 
alpha, gamma, mu, and nu but once again no statistically significant associations were 
observed. 
Most of the increased risks of SCC have been associated with seropositivity to 
the genus beta types as a group, although cutaneous HPV type-specific associations 
have also been observed.  For example, in the Australian population, antibodies against 
HPV 8 demonstrated the strongest association with SCC of 9.3 (95% CI=1.9–45.6)(73).  
81 
 
Antibodies against HPV 8 have also been associated with SCC in four other case-control 
studies(30, 32, 73, 101).  In the Italian population, increased risks of SCC were observed 
with seropositivity to HPV 15 (OR=2.8, 95% CI=1.1-7.1), HPV 17 (OR=2.6, 95% 
CI=1.01-6.5) and HPV 38 (OR=3.0,95% CI=1.2-7.9)(37).  Antibodies to HPV 38 were 
also associated with SCC in the Dutch population (OR=3.0, 95% CI=1.1-8.4)(30). 
1. k. UV radiation exposure and cutaneous HPV infection in relation to squamous 
cell carcinoma 
Several lines of evidence suggest that UV radiation exposure is associated with 
cutaneous HPV infection, and that these two factors may play a synergistic role in the 
development of cutaneous SCC.  UV radiation produces distinct mutations in DNA, and 
tandem mutations, specifically CC→TT transitions in the TP53 gene (thymine dimers), 
are a hallmark of UV-induced DNA damage in SCC(42).  UV-B radiation can also 
stimulate the promoter activity of HPV 5 and 8(39). In turn, the E6 proteins of genus beta 
HPV types have been shown to inhibit UV radiation-induced apoptosis through p53-
independent pathways(45, 46), and cells expressing the E6 protein of HPV type 5 have 
reduced capacity to repair UV radiation-induced thymine dimers(43).  In addition, HPV 
38 E6 and E7 can alter the regulation of cell cycle checkpoints activated by UV 
radiation(41).   
Epidemiologic evidence also supports the association between UV radiation 
exposure and cutaneous HPV infection.  For example, individuals from the Leiden Skin 
Cancer study with a history of painful sunburns as a teenager were more likely to have 
EV-HPV DNA in plucked eyebrow hair samples than individuals without a similar 
history(104) (OR=1.74, 95% CI=1.04-2.91).  Results from two case-control studies of 
SCC suggest that skin sensitivity to UV radiation and cutaneous HPV infection as 
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measured by seropositivity may interact synergistically.  Among genus beta HPV-
seronegative individuals in the New Hampshire study, individuals who reported getting a 
severe sunburn with blistering had a non-significant two-fold risk of SCC as compared to 
those who tanned without a sunburn(34) (OR=2.0, 95% CI=0.8-4.9).  However, for those 
who were genus beta HPV-seropositive, having skin sensitive to UV radiation was 
associated with a statistically significant 4.6-fold risk of SCC(34) (OR=4.6, 95% CI=1.2-
18.0).  Similarly, statistically significant joint effects were observed between genus beta 
HPV seropositivity and risk factors for SCC such as skin color, propensity to sunburn, 
and intensity of sun exposure for risk of SCC among residents from Queensland, 
Australia(44).  Genus beta HPV seropositive participants with fair skin color were more 
likely to have SCC (OR=26.9, 95% CI=6.6-111) compared to being HPV seronegative 
with olive-medium skin color.  Having a high propensity to sunburn (always or most of 
the time) when sun exposed and being genus beta HPV seropositive was strongly 
associated with SCC (OR=8.5, 95% CI=2.4-29.3) compared to being genus beta HPV 
seronegative and experiencing a sunburn never, rarely, or sometimes when sun 
exposed.  Additionally, high UV exposure and genus beta HPV seropositivity was 
strongly associated with SCC (OR=10.8, 95% CI=1.1-103) compared to participants with 
low UV exposure who were genus beta HPV seronegative.   
1. l. Seroprevalence of cutaneous human papillomavirus infection 
Cutaneous HPV seroprevalence among healthy persons varies across studies.  
For example, among the eight studies reporting genus-specific seroprevalence for beta 
HPV types, seroprevalence ranged from 12.3 and 12.5% in the Netherlands(30, 104), to 
13% in Australia(73), to 24.7% in New Hampshire (NH) (34), to 26.3% in Germany(35), 
to 41% in Sweden and Austria(71), to 58% in the UK(29), and up to 70.8% in 
Florida(78).  Genus alpha HPV seroprevalence was 11.2 % in Germany(35) compared 
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to 48.4% in Florida(78).  Among the three studies reporting estimates for genus gamma 
and genus mu HPV types, the seroprevalence was highest in Florida with 53.3% and 
44.3%(78)  followed by 51% and 28% in the UK(29) and 26.8% and 27.6% in 
Germany(35), respectively, for being seropositive to at least one HPV type belonging to 
genus gamma or genus mu.  For the single HPV type belonging to genus nu, 
seroprevalence ranged from 7.4% in Germany(35), to 14.0% in the UK(29), to 16.3% in 
Florida(78) to 27.0% in Italy(37).     
There are several possible explanations for the observed differences in 
cutaneous HPV type-specific seroprevalences across studies.  First, the genus-specific 
seroprevalence estimates are based on different numbers of HPV types.  Second, there 
may be differences resulting from the use of different laboratory techniques for antibody 
detection and non-standardized cut-off definitions.  However, there is substantial 
variation in estimates even among studies that used similar techniques.  For example, 
genus beta seroprevalences ranged from 12.3% to 41% in studies that used ELISA 
assays for antibody detection(30, 71, 73, 104) and from 24.7% to 70.8% in studies that 
used Luminex techniques(29, 34, 35, 78).  Additionally, variation in cutaneous HPV 
seroprevalence across studies may be due in part to differences in the underlying 
distribution of factors associated with HPV infection, such as age and sun exposure.  For 
example, the single case-control study published from the U.S. was conducted in NH, 
where antibodies to genus beta HPV types overall were detected in 25% of controls(34).  
Data from our own study of healthy volunteers in Florida using the same laboratory 
methods as the NH study indicate that seroprevalence for the same HPV types is much 
higher in Florida(78) (57%), where sun exposure is greater.  As described above in 
section 1.k., a statistically significant association was observed between cutaneous HPV 
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seropositivity and SCC among participants with skin sensitive to sun in the NH 
study(34).   
1. m. Additional factors related to cutaneous human papillomavirus infection 
 Among the case-control studies of NMSC, only a few studies report independent 
findings of cutaneous HPV positivity in association with demographic and skin cancer 
risk factors among the control subjects. Factors associated with cutaneous HPV 
positivity may differ in individuals with a history of NMSC compared to individuals without 
a similar history.  For example, (as previously mentioned in section 1.k.), in the Dutch 
population from the Leiden Skin Cancer Study(104), it was observed that control 
subjects with a history of painful sunburns between ages 13 to 19 years were almost two 
times more likely to be positive for cutaneous HPV DNA in eyebrow hairs (OR=1.74, 
95% CI=1.04-2.91; p=0.04), but similar associations were not observed among SCC 
cases (OR=1.18, 95% CI=0.54-2.60; p=0.68).  Increasing age showed a small significant 
increase in risk for cutaneous HPV DNA among the controls (OR=1.04, 95% CI=1.01-
1.06; p=0.01) but not in the SCC cases (OR=1.01, 95% CI=0.96-1.06; p=0.63).  A 
significant inverse association was observed among control subjects with high levels of 
lifetime sun exposure compared to individuals without a history of frequent sun 
exposure.  For example, control subjects with a medium level or high level of sun 
exposure were 46% and 55%, respectively, less likely to be positive for cutaneous HPV 
DNA (medium level: OR=0.54, 95% CI=0.30-0.98; high level: OR=0.45, 95% CI=0.22-
0.92; p=0.057).  No associations between lifetime sun exposure and cutaneous HPV 
DNA positivity were observed among SCC cases.  When looking at seropositivity in the 
same Dutch population, sun exposure related factors were not observed to be 
associated with cutaneous HPV infection in the control subjects.  Among the SCC cases, 
fair skin compared to dark type (as defined by the Fitzpatrick classification of skin type) 
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was independently associated with higher cutaneous HPV seroprevalence (OR=3.45, 
95% CI=1.18-10.0).  No significant associations with age, sex, or other sun related 
factors were observed for cutaneous HPV seropositivity among control subjects or SCC 
cases. 
Among Swedish individuals, Andersson and colleagues conducted multivariate 
analyses to investigate the independent associations between several demographic and 
skin cancer risk factors, such as age, sex, skin type, history of sunburns, smoking, and 
diagnosis (benign, actinic keratosis, SCC, and BCC) with cutaneous HPV 
seropositivity(71).  Increased seropositivity for genus beta types was observed for fair 
skinned individuals (OR=2.47, 95% CI=0.91-6.69) compared to dark skinned individuals, 
but this association was not statistically significant.  Smokers and persons who always 
sunburned were 1.43 and 1.36 times, respectively, more likely to be positive for 
cutaneous HPV antibodies compared to non-smokers and persons that do not sunbathe, 
but neither of these associations was statistically significant. Age, sex, and diagnosis 
showed no associations with genus beta HPV seropositivity.  However, cutaneous HPV 
seroprevalence was observed to be higher among individuals that were male, older in 
age, fair skinned, smokers, had a high propensity to sunburn, and a diagnosis of SCC. 
1. n. Limitations in literature 
 There are several limitations of the current literature that should be addressed.  
Evidence supporting the use of sunscreen to protect against skin cancer comes from two 
randomized controlled trials (RCT) conducted among Australian residents, where the 
amount, frequency, and formulation of sunscreen being used are controlled.  
Observational studies have not provided evidence of the protective effect of sunscreen 
use against NMSC but instead demonstrated increased risk for NMSC with sunscreen 
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use, possibly due to prolonged sun exposure while using sunscreen (i.e. intentional sun 
exposure), a factor not adjusted for in most of the analyses presented, as well as 
changes in sun exposure behaviors (i.e. using sunscreen more frequently) after first 
diagnosis of skin cancer.  Furthermore, the sunscreen formulation being applied by 
participants enrolled in observational studies is not the same being applied by 
participants on a RCT.  Additionally, most analyses presented in the literature did not 
consider site of sunscreen use compared to site of NMSC diagnosis.  Further 
observational studies are needed to better understand the effectiveness of sunscreen 
products in the general population.  This will allow better education to consumers for the 
use of sunscreen and other sun safe behaviors to protect against sunlight exposure and 
prevent/reduce NMSC.  
Studies investigating the associations between amount, patterns, and timing of 
sun exposure and NMSC are few in number and have been limited to populations 
outside of the United States(51-53), with the exception of the study conducted by Vitasa 
et al among watermen from Maryland.  However, Vitasa and colleagues measured 
cumulative exposure to UVB while the other studies(51-53) conducted among residents 
from Southern Europe and Australia used indirect measurements of sunlight exposure 
such as hours spent outdoors. Measuring lifetime sun exposure is difficult and 
measurement methods have varied across studies making it difficult to compare results.   
Additional limitations of case-control studies, such as recall bias and inability to adjust for 
time dependent variables, also permit for measurement errors.  This error may lead to 
biased estimates of the effect being measured.  For example, difficulty in remembering 
the number of hours of sunlight exposure during one’s teens, 20s, and 30s when older in 
life (i.e. 60s – 70s) allows for measurement error not only in calculating the number of 
hours of sun exposure over a lifetime or on working or non-working days but in 
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estimating the association between patterns and timing of sun exposure and NMSC as 
well.  Additionally, inability to adjust for time dependent variables presents challenges in 
identifying the true association between two factors.  For example, changes in sun 
exposure behaviors, such as an increase in the frequency of sunscreen use after being 
diagnosed with skin cancer for the first time allows for measurement error in estimating 
the potential protective effects of sunscreen use against NMSC; a possible explanation 
for the associations observed in previous studies where sunscreen use appears to be a 
risk factor for NMSC.      
Evidence in the published literature investigating the association between 
cutaneous HPV and NMSC is limited and more epidemiologic studies are needed to 
better understand the association between UV radiation exposure and cutaneous HPV 
infection as they relate to NMSC development.  A majority of the studies investigating 
the association between cutaneous HPV seropositivity and NMSC did not include 
cutaneous HPV types in genera other than beta and did not present stratified analyses 
by factors, such as sun exposure, that may explain the variability observed across study 
populations.  This is important because the findings from the studies conducted in New 
Hampshire (NH) (34) and Australia(44) showed differences between cutaneous HPV 
seroprevalence and SCC by sun related factors, such as level of UV exposure, skin 
color, and propensity to sunburn.  Australian residents receive high ambient solar 
radiation and experience the highest incidence of skin cancer worldwide, very different 
from what is experienced by residents in NH.  Furthermore, the associations between 
cutaneous HPV seropositivity and BCC and SCC presented in section 1.j. are based on 
different numbers of cutaneous HPV types tested, limiting the comparability of results 
across studies.  For example, the NH(34) study tested 8 types in genus beta; where as 
study conducted on the Italian(37) population tested 15 HPV types in genus beta and the 
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study from the UK(29) tested 16 HPV types.  Comparing estimates based on a different 
number of genus beta HPV types tested may explain the variability observed across 
studies.  
1. o. Public health significance 
Non-melanoma skin cancer (NMSC), comprised of squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC), is the most frequently occurring cancer among 
U.S. men and women.  Exposure to Ultraviolet (UV) radiation is an established risk 
factor for NMSC, but despite the current knowledge about the harm of sun exposure, 
and increased use of sunscreen, NMSC incidence rates continue to increase, 
emphasizing the critical need to better understand the role of sunscreen use in 
preventing NMSC and differences in sunlight exposure response relationships for BCC 
and SCC.  Furthermore, it’s important to identify additional risk factors for NMSC that 
may better characterize individuals at high risk and aid in the development of novel 
prevention strategies.  
Evidence demonstrating the preventative capabilities of sunscreen use and SCC 
has been provided by randomized controlled trials and observational studies have 
focused on the associations between sunscreen use and BCC.  Additional observational 
studies are needed to better understand the effectiveness of sunscreen and its 
association with SCC.  Further studies are also needed to understand how anatomical 
site specific sunscreen use relates to anatomical site of NMSC diagnosis.  Many 
epidemiologic studies provide evidence for the role of UV radiation exposure in the 
etiology of all types of skin cancer.  However, few studies have formally evaluated the 
association between patterns and timing of sunlight exposure as they relate to BCC and 
SCC.  Understanding how sunlight exposure response differs for BCC and SCC is 
important for better educating the public in sun safe behaviors.  Simply advising a 
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reduction in sunlight exposure will not help reduce the incidence of NMSC if changes in 
sun exposure patterns are related to skin cancer development.  For example, reducing 
continuous sunlight exposure (i.e. high doses of daily sunlight exposure) may decrease 
the incidence of SCC but not BCC if intermittent sun exposure, as received on holidays 
and vacations, is still received in high doses.  Epidemiologic studies conducted in 
several countries have demonstrated an association between cutaneous HPV infection 
and NMSC, particularly SCC, and there is limited evidence to support the interaction 
between sunlight exposure and cutaneous HPV seropositivity as they relate to SCC.  
There is growing interest in utilizing a vaccine approach to preventing cancers caused by 
HPV, such as NMSC.  However, much remains to be understood regarding the 
epidemiology of cutaneous HPV infections and their relationship with UV radiation 
exposure and NMSC development before such an approach can be incorporated into 
public health practice.   
The goal of the research study was to better understand the relationships 
between sunscreen use and differences in sunlight exposure responses for BCC and 
SCC.  Furthermore, the research project had the potential to provide evidence for the 
interaction between sunlight exposure and cutaneous HPV seropositivity as it relate to 
BCC and SCC.  Individuals who reside in Florida have a significantly increased risk of 
developing NMSC compared to residents of northern US states(34) due to higher levels 
of UV radiation exposure. As mentioned earlier NMSC incidence rates continue to rise, 
emphasizing the public health importance of this highly prevalent cancer and highlighting 
the need for an increased understanding of its etiology and control. 
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Appendix 2: Supplementary Tables 
 
Sunscreen use as prevention for basal cell and squamous cell carcinoma 
Sunscreens were originally formulated to protect against ultraviolet (UV)-induced 
sunburns, thought to be caused mostly by UV-B radiation.  However, through laboratory 
studies in rodents, it was revealed that sunscreens had the potential to reduce UV-
induced skin cancer, such as SCC(86).  Animal models have not supported similar 
findings for BCC or melanoma.  Despite the lack of evidence that sunscreens can 
protect against BCC or melanoma occurrence, sunscreen products are advocated for 
the prevention of all types of skin cancers.  Currently available sunscreens provide broad 
spectrum coverage (UV-A and UV-B).  However, observational studies have found 
sunscreen use to be associated with increased risk for BCC and an increased incidence 
of melanocytic nevi among children and adolescents.  Randomized controlled trials from 
the published literature demonstrated that sunscreens had the ability to reduce the 
occurrence of solar keratoses (precursors for SCC) and of SCC, however, no effect was 
observed for BCC(87-89).   
Evidence supporting the use of sunscreen to protect against skin cancer comes 
from two randomized controlled trials (RCT) conducted among Australian residents, 
where the amount, frequency, and formulation of sunscreen being used are controlled.  
Observational studies have not provided evidence of the protective effect of sunscreen 
use against NMSC but instead demonstrated increased risk for NMSC with sunscreen 
use, possibly due to prolonged sun exposure while using sunscreen (i.e. intentional sun 
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exposure), a factor not adjusted for in most of the analyses presented, as well as 
changes in sun exposure behaviors (i.e. using sunscreen more frequently) after first 
diagnosis of skin cancer.  Additionally, skin sensitivity to sunlight exposure may influence 
the amount of time exposed to sunlight and in turn the frequency of sunscreen use. 
Results presented in Tables A1 through A4 demonstrated the influence skin 
sensitivity and tanning ability to sunlight exposure have on the associations between 
sunscreen use and NMSC.  Associations between sunscreen use and BCC/SCC 
stratified by skin reaction to one hour of sunlight exposure in the mid-day sun are 
presented below in tables A1 and A2.  Despite the lack of power to detect statistically 
significant associations, information in the tables below provide evidence that using 
sunscreen either some of the time or rarely/never when exposed to sunlight exposure 
increased the risk of both BCC and SCC among individuals with a tendency to burn.  In 
contrast, among individuals reporting no change in skin color or with a lesser tendency 
to tan from sunlight exposure, applying sunscreen some of the time or rarely/never when 
in the sun, increased the risk for BCC and SCC, compared to applying sunscreen often 
or always. 
Table A1. Associations between sunscreen use and basal cell carcinoma stratified 
by cutaneous sensitivity to sunlight exposure for 1 hour in the mid-day sun 
n % n % OR1 95% CI n % n % OR1 95% CI n % n % OR1 95% CI
Apply SPF2 ≥15
Often/always 13 (30.2) 6 (30.0) 1.00 (reference) 52 (36.1) 27 (41.5) 1.00 (reference) 59 (47.6) 47 (36.7) 1.00 (reference)
Sometimes 13 (30.2) 3 (15.0) 0.25 (0.04- 1.63) 54 (37.5) 15 (23.1) 0.39 (0.17- 0.89) 29 (23.4) 40 (31.3) 1.71 (0.88- 3.31)
Rarely/Never 17 (39.5) 11 (55.0) 0.35 (0.06- 2.03) 38 (26.4) 23 (35.4) 0.61 (0.27- 1.38) 36 (29.0) 41 (32.0) 1.13 (0.60- 2.12)
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and gender
2SPF = sun protection factor
Controls
No change in skin color
Tan with no sunburn or mild burn that 
turns to a tan Sunburn with or without blisters
Controls BCC Controls BCC BCC
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Table A2. Associations between sunscreen use and squamous cell carcinoma 
stratified by cutaneous sensitivity to sunlight exposure for 1 hour in the mid-day 
sun 
Variable n % n % OR1 95% CI n % n % OR1 95% CI n % n % OR1 95% CI
Apply SPF2 ≥15
Often/always 13 (30.2) 5 (23.8) 1.00 (reference) 52 (36.1) 11 (22.4) 1.00 (reference) 59 (47.6) 35 (38.9) 1.00 (reference)
Sometimes 13 (30.2) 6 (28.6) 0.84 (0.17- 4.01) 54 (37.5) 21 (42.9) 1.36 (0.54- 3.40) 29 (23.4) 29 (32.2) 1.18 (0.55- 2.54)
Rarely/Never 17 (39.5) 10 (47.6) 0.85 (0.19- 3.67) 38 (26.4) 17 (34.7) 1.08 (0.40- 2.89) 36 (29.0) 26 (28.9) 0.73 (0.35- 1.55)
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and gender
2SPF = sun protection factor
Controls SCC
No change in skin color
Tan with no sunburn or mild burn that 
turns to a tan Sunburn with or without blisters
Controls SCC Controls SCC
 
 
Similar associations were investigated between sunscreen use and BCC/SCC 
stratified by tanning ability to repeated sunlight exposure.  As demonstrated in Table A3, 
differences in tanning ability did not appear to alter the observed associations between 
frequency of sunscreen use and BCC risk.  With the exception of applying sunscreen 
some of the time by individuals that reported being unable to tan from repeated sunlight 
exposure, frequency of sunscreen use and SCC (Table A4) risk did not appear to differ 
by one’s ability to tan.   
Table A3. Associations between sunscreen use and basal cell carcinoma stratified 
by tanning ability to repeated sunlight exposure 
Variable n % n % OR1 95% CI n % n % OR1 95% CI n % n % OR1 95% CI
Apply SPF ≥15
Often/always 68 (37.0) 37 (35.9) 1.00 (reference) 42 (41.2) 33 (35.5) 1.00 (reference) 12 (54.5) 7 (46.7) 1.00 (reference)
Sometimes 56 (30.4) 22 (21.4) 0.52 (0.26- 1.05) 36 (35.3) 35 (37.6) 1.14 (0.56- 2.31) 3 (13.6) 1 ( 6.7) 0.47 (0.03- 8.58)
Rarely/Never 60 (32.6) 44 (42.7) 0.77 (0.40- 1.47) 24 (23.5) 25 (26.9) 0.92 (0.42- 2.03) 7 (31.8) 7 (46.7) 1.33 (0.26- 6.68)
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and gender
2SPF = sun protection factor
Tans easily Tan if you work at it Unable to tan
Controls BCC Controls BCC Controls BCC
 
 
Table A4. Associations between sunscreen use and squamous cell carcinoma 
stratified by tanning ability to repeated sunlight exposure 
Variable n % n % OR1 95% CI n % n % OR1 95% CI n % n % OR1 95% CI
Apply SPF ≥15
Often/always 68 (37.0) 16 (26.2) 1.00 (reference) 42 (41.2) 24 (32.4) 1.00 (reference) 12 (54.5) 12 (48.0) 1.00 (reference)
Sometimes 56 (30.4) 23 (37.7) 0.95 (0.42- 2.18) 36 (35.3) 27 (36.5) 0.88 (0.39- 2.02) 3 (13.6) 5 (20.0) 2.15 (0.26- 17.8)
Rarely/Never 60 (32.6) 22 (36.1) 0.65 (0.28- 1.54) 24 (23.5) 23 (31.1) 0.94 (0.39- 2.27) 7 (31.8) 8 (32.0) 0.97 (0.20- 4.68)
1Odds ratios (OR) and 95% confidence intervals (CI) adjusted for age and gender
2SPF = sun protection factor
Tans easily Tan if you work at it Unable to tan
Controls SCC Controls SCC Controls SCC
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If sunscreen use has the potential to protect against skin cancer development, 
we would expect a reduced risk in BCC and SCC among individuals using sunscreen 
products always or often and possibly some of the time when exposed to sunlight.  
However, in addition to a person’s skin reaction to sunlight exposure, factors such as 
cumulative ambient solar radiation, recreational and vacation activities, clothing worn 
when exposure to UVR, and geographic residence, need to be considered 
simultaneously when investigating the potential preventive effects of sunscreen use in 
skin cancer development, especially in observational studies.  Due to a small sample 
and therefore, lack of power to detect statistically significant associations, it’s difficult to 
make conclusions on the associations between sunscreen use and BCC/SCC in the 
current study population.  We were not able to control for the factors listed above and we 
were not able to identify whether or not individuals that reported skin sensitivity and 
rarely or never using sunscreen as also limiting sunlight exposure.  
With the knowledge about the harmful effects of UV radiation, the use of 
sunscreens has increased.  However, the incidence of NMSC continues to rise, perhaps 
because individuals who use sunscreen spend more time in the sun under the 
assumption that they are protected from the harmful effects of UV radiation.  There is 
experimental evidence that suggests sunscreens are protective against SCC, but similar 
results have not been observed for BCC.  Additionally, no observational studies have 
been able to formally evaluate the relationship between sunscreen use and NMSC, 
partly due to small sample sizes that do not allow for stratified analyses and 
simultaneous assessment of multiple factors that influence sunscreen use and its 
potential protective effects. 
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